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CHAPTER 1 
 
INTRODUCTION 
 
Parts of this chapter have been submitted for publication in the journal of 
Advances in Experimental Medicine and Biology, Springer (invited review). 
 
1. Role of CL in cellular signaling – an overview 
It is not unusual to find even current depictions of membranes as 
homogenous lipid matrices that function primarily to support the allegedly 
important protein molecules embedded within. This belies the fascinating 
discoveries in the past two decades of cellular and organelle-specific functions 
attributed to individual membrane lipids, and of the plethora of regulatory and 
signaling molecules derived from glycerolipids and sphingolipids.  In this light, it 
is essential to elucidate the functions of specific membrane lipids and the cellular 
consequences of their depletion.   
A phospholipid that has been the focus of considerable attention relatively 
recently - although it was first isolated and purified from beef heart in 1942 
(Pangborn, 1942; Pangborn, 1947), is cardiolipin (CL). CL is structurally unique. 
In contrast to the other membrane phospholipids, in which a single glycerol 
backbone is acylated to two fatty acid chains, CL contains two phosphatidyl 
groups (linked to a glycerol backbone) and four fatty acyl chains. It is enriched in 
energy harvesting membranes of mitochondria, chloroplasts, bacterial plasma 
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membranes, and hydrogenosomes, underscoring the importance of this lipid in 
energy production (Corcelli, 2009; Depalo et al., 2004; Dowhan, 1997). CL is 
tightly associated with mitochondrial proteins and respiratory chain complexes 
and is essential for their optimal activity (Fry et al., 1980; Fry and Green, 1980; 
Fry and Green, 1981; Lange et al., 2001a; Pfeiffer et al., 2003). In the inner 
membrane, CL provides structural stability to membrane proteins through 
hydrophobic and electrostatic interactions.  
In light of its association with the respiratory apparatus, the role of CL in 
mitochondrial bioenergetics was not entirely unexpected. Interestingly, however, 
recent studies carried out primarily in yeast indicate that CL is also required for 
cellular functions that are not directly associated with oxidative phosphorylation.  
In accordance with a broad definition of a ‘bioactive lipid’ as one in which 
changes in levels lead to functional consequences (Hannun and Obeid, 2008), 
perturbation of CL composition (including CL levels, acyl species, and degree of 
peroxidation) leads to dramatic cellular consequences: (1) Alterations in CL 
levels and acyl chain composition increases the recruitment to the mitochondria 
of cytosolic proteins that trigger apoptosis (Kagan et al., 2005; Kuwana et al., 
2002; Schug and Gottlieb, 2009). (2) Perturbation of CL synthesis or remodeling 
leads to increased production of reactive oxygen species (ROS), which induces 
aging (Cao et al., 2009; Chen et al., 2008a; Lee et al., 2006; Li et al., 2012; Li et 
al., 2010; Paradies et al., 2010). (3) Blocking CL synthesis in yeast at the first 
step of the pathway deleteriously affects cell wall biogenesis and alters the 
response of two signaling pathways, the protein kinase C (PKC)-Slt2 mitogen 
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activated protein kinase (MAPK) and the high osmolarity glycerol (HOG) 
pathways (Zhong et al., 2005; Zhong et al., 2007; Zhou et al., 2009). (4) The 
inability of yeast cells to synthesize CL leads to decreased vacuolar function and 
reduced V-ATPase activity, suggesting that CL mediates cross talk between 
mitochondria and the vacuole (Chen et al., 2008b). 
 
2.  CL biosynthesis and remodeling 
One of the most intriguing aspects of CL biosynthesis is that the lipid that 
is initially synthesized contains primarily saturated fatty acids, while the mature 
CL that is essential for normal cellular function contains primarily unsaturated 
fatty acids.  The distinct composition of acyl chains is achieved through a highly 
conserved pathway of synthesis and remodeling, as shown in Fig. 1.1. The first 
step is catalyzed by phosphatidylglycerolphosphate (PGP) synthase (Pgs1), 
which converts CDP-diacylglycerol (DAG) and glycerol-3-phosphate (G-3-P) to 
PGP (Chang et al., 1998a; Kawasaki et al., 1999). PGP is dephosphorylated to 
phosphatidylglycerol (PG) by PGP phosphatase (Gep4) (Osman et al., 2010; 
Zhang et al., 2011). The mammalian homologue of the yeast GEP4 gene was 
recently identified as protein tyrosine phosphatase localized in the mitochondrion 
1 (Zhang et al., 2011). CL synthase (Crd1) catalyzes an irreversible 
condensation reaction in which the phosphatidyl group of CDP-DAG is linked to 
PG via cleavage of a high-energy anhydride bond to form CL (Chang et al., 
1998b; Chen et al., 2006; Hostetler et al., 1971; Hostetler et al., 1972; 
Houtkooper et al., 2006; Jiang et al., 1997; Tamai and Greenberg, 1990; Tuller et 
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al., 1998).  CL synthase does not show strong preference for specific fatty acyl 
chains (Hostetler et al., 1975; Houtkooper et al., 2006; Nowicki et al., 2005).  
How, then, is acyl specificity achieved? The newly synthesized CL undergoes 
deacylation by a CL-specific deacylase (Cld1), which is homologous to the 
mammalian phospholipase A2 (Beranek et al., 2009; Mancuso et al., 2009; 
Mancuso et al., 2007). Cld1 removes one saturated fatty acyl chain from CL to 
form monolysocardiolipin (MLCL) (Beranek et al., 2009). The transacylase 
tafazzin (Taz1) reacylates MLCL with an unsaturated fatty acid to form mature 
CL (Gu et al., 2004; Xu et al., 2003b; Xu et al., 2006). Taz1 carries out a 
bidirectional exchange of acyl chains between CL and phosphatidylcholine (PC) 
to sequentially replace the fatty acyl chains from all four acyl positions of CL 
(Malhotra et al., 2009). The end result of this exchange is molecular symmetry of 
CL molecules across the eukaryotic kingdom, from yeast to humans, which is 
characteristic of the organism and of specific tissues and organs (Schlame et al., 
2005). For example, in yeast, the mature form of CL contains oleic acid, while CL 
in the normal human heart is primarily tetralinoleoyl-CL (L4-CL) (Schlame et al., 
2005). A deficiency of tafazzin in humans leads to a complete absence of L4-CL, 
resulting in the severe cardiomyopathy observed in BTHS. 
While tafazzin is the only known yeast enzyme that adds fatty acyl chains 
to MLCL, two other enzymes in addition to tafazzin remodel CL in mammalian 
cells. MLCL acyltransferase-1 (MLCLAT1), isolated and purified from pig liver 
mitochondria, shows specificity for linoleate (Taylor and Hatch, 2003). Thus,  
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Figure 1.1 Synthesis and remodeling of CL in yeast. CL synthesis begins with 
the conversion of CDP-diacylglycerol (CDP-DG) to 
phosphatidylglycerolphosphate (PGP) by PGP synthase (encoded by PGS1). 
PGP is dephosphorylated to phosphatidylgylcerol (PG) by GEP4-encoded PGP 
phosphatase. CL synthase (Crd1 define in the text for either lower or capital 
case) converts PG to premature CL containing primarily saturated fatty acids 
(FA). CL is deacylated by CL deacylase (Cld1) to monolyso-CL (MLCL), which is 
reacylated by the TAZ1-encoded enzyme tafazzin to mature CL containing 
primarily unsaturated fatty acids. The yeast gene names are depicted in green, 
while phospholipids and their intermediates are shown in red. 
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over-expression of MLCLAT1 in tafazzin-deficient BTHS lymphoblasts increased 
incorporation of linoleic acid into CL, and RNAi knockdown of MLCLAT1 in HeLa 
cells showed reduced linoleic acid inclusion in CL (Taylor and Hatch, 2009). The 
biological function of this enzyme is not clear.  A second enzyme, acyl-
CoA:lysoCL acyltransferase 1 (ALCAT1), identified in mouse, was initially 
thought to be located in the endoplasmic reticulum, but was subsequently 
determined to be present in the mitochondrial-associated membranes, where 
phospholipid traffic between the endoplasmic reticulum and the mitochondria 
takes place (Cao et al., 2004; Li et al., 2010). In contrast to MLCLAT1, ALCAT1 
shows no specificity for linoleic acid. ALCAT1 was shown to catalyze CL 
remodeling to incorporate long chain polyunsaturated fatty acyl chains such as 
docosahexaenoic acid (DHA) (Li et al., 2010). Enhanced incorporation of 
polyunsaturated fatty acyl chains in CL makes it more susceptible to oxidative 
damage by ROS, causing early peroxidation (Hong et al., 2002; Ng et al., 2005; 
Watkins et al., 1998). ALCAT1 null mutant mice exhibit elevated CL levels along 
with increased L4-CL (Li et al., 2012; Li et al., 2010), whereas overexpression of 
ALCAT1 has been shown to decrease total CL levels and increase incorporation 
of long chain polyunsaturated fatty acyl chains (Sparagna and Lesnefsky, 2009). 
These findings suggest that ALCAT1 may negatively regulate CL biosynthesis. 
In light of the importance of CL in cellular function, it is not surprising that 
perturbation of CL synthesis leads to serious illness.  The most direct example of 
this link is seen in BTHS, a life-threatening illness characterized by dilated 
cardiomyopathy and sudden death from arrhythmia (Barth et al., 1999a; 
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Christodoulou et al., 1994).  BTHS results from mutation in the CL remodeling 
enzyme tafazzin (Bione et al., 1996a; Xu et al., 2003a). This leads to an 
abnormal CL profile characterized by decreased total CL, increased monolyso-
CL, and aberrant CL acylation, most notably the loss of the predominant CL 
species in normal myocardium, L4-CL (Vreken et al., 2000). How these 
abnormalities cause the associated pathology in BTHS is not known (Schlame et 
al., 2002). 
CL abnormalities have also been observed in heart failure (Saini-Chohan 
et al., 2009; Sparagna et al., 2007). Heart failure due to dilated cardiomyopathy 
is the primary cause of death in diabetic patients (Garcia et al., 1974; Nichols et 
al., 2001). Metabolic perturbations observed in diabetic cardiomyopathy include 
increased utilization of fatty acid substrates, decreased utilization of glucose, and 
mitochondrial dysfunction (Fang et al., 2004; Poornima et al., 2006; Wang et al., 
2006). However, the molecular mechanism that leads to heart failure in diabetic 
patients is not known. Interestingly, a decrease in CL levels and alterations in CL 
acyl species were found in early stages of diabetes induced by streptozotocin in 
mice, suggesting that mitochondrial dysfunction and cardiomyopathy may be due 
to alterations in CL metabolism (Han et al., 2005; Han et al., 2007). The 
decrease in CL levels may result from remodeling of CL fatty acyl species with 
DHA, which is known to cause CL peroxidation by ROS (Hong et al., 2002; Ng et 
al., 2005; Watkins et al., 1998). In summary, depletion of CL content and 
alterations in CL fatty acyl species lead to BTHS, and may also contribute to 
pathological conditions and metabolic perturbations in other human disorders. 
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3.  CL and apoptosis 
Perturbations in CL levels and acyl composition play a crucial role in 
regulating apoptosis, the complex process leading to programmed cell death.  
The role of CL in apoptosis derives from its interactions with cytochrome c (Cyt c) 
and with apoptotic proteins (Fig. 1.2).  
i) CL and Cyt c.  Interactions between CL and Cyt c are an important 
determinant of apoptosis. Cyt c, which transfers electrons from complex III to 
complex IV, is bound to the outer leaflet of the mitochondrion inner membrane 
through interactions with CL (Gorbenko, 1999; Iverson and Orrenius, 2004). The 
binding of Cyt c to CL is essential to anchor it to the inner membrane, and 
release of Cyt c to the cytosol serves as a signal to recruit apoptotic proteins to 
the mitochondria to initiate apoptosis (Choi et al., 2007; Petrosillo et al., 2006; 
Spooner and Watts, 1992; Tuominen et al., 2002). CL binds Cyt c in two different 
conformations - a loosely bound state that is facilitated by means of electrostatic 
interactions, and a tightly bound state that is mediated by hydrophobic 
interactions in which Cyt c is partially embedded in the inner membrane 
(Gorbenko, 1999; Iverson and Orrenius, 2004). Release of Cyt c from CL 
requires dissociation of both electrostatic and hydrophobic interactions (Ott et al., 
2002). The production of ROS may alter the CL-Cyt c association (Ott et al., 
2002; Petrosillo et al., 2006; Petrosillo et al., 2003). Alternatively, the 
peroxidation of CL by hydrogen peroxide generated in the mitochondria leads to 
the release of Cyt c from the tightly bound state into the intermembrane space 
(Belikova et al., 2006; Kagan et al., 2005).  
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Figure 1.2. Perturbation of CL metabolism triggers apoptosis. The binding of 
cytochrome c (Cyt c) to CL is essential to anchor it to the inner mitochondrial 
membrane, facing the intermembrane space. Peroxidation of CL (CL-OOH) by 
reactive oxygen species (ROS) leads to release of Cyt c to the cytosol, which 
serves as a signal to initiate apoptosis. Caspase-8 cleaves Bid protein to its 
active form, truncated Bid (t-Bid). Binding of t-Bid to CL enhances translocation 
of CL to the outer mitochondrial membrane, which facilitates targeting of 
apoptotic proteins (Bak and Bax) to the outer membrane. 
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 ii) Recruitment of apoptotic proteins. An early trigger of apoptosis is the 
change in CL composition in the mitochondrial inner and outer membranes, 
followed by dissipation of the membrane potential and flipping of 
phosphatidyserine (PS) to the external surface of the plasma membrane (Garcia 
Fernandez et al., 2002; Thiagarajan and Tait, 1990). A diverse set of apoptotic 
proteins such as t-Bid, Bax, Bak, and caspase-8 are recruited to the 
mitochondrial surface of cells undergoing apoptosis in a CL-dependent manner 
(Gonzalvez et al., 2010; Gonzalvez et al., 2008; Li et al., 1998). Upon activation, 
caspase-8 migrates to the mitochondrial outer membrane in regions where CL is 
present. Caspase-8 is said to cleave Bid to its active form, tBid (truncated Bid). A 
significant amount of CL is translocated from the inner to the outer mitochondrial 
membrane, which likely serves as a signal for binding of the apoptotic proteins 
(Gonzalvez et al., 2005; Kuwana et al., 2002; Lutter et al., 2000). The binding of 
t-Bid to CL is thought to further increase CL transfer to the outer membranes. 
Alternatively, apoptotic proteins may be guided to the mitochondria by means of 
altering the outer membrane charge (Heit et al., 2011). By increasing the CL 
content, the mitochondrial outer membrane may accrue a more negative charge, 
which serves as a targeting signal for recruiting polycationic apoptotic proteins to 
the mitochondria (Aguilar et al., 1999; Lutter et al., 2000). Consistent with this, 
ectopic overexpression of a CL-binding protein masked the negative charge on 
the membrane and inhibited apoptosis (Heit et al., 2011). The recruitment to and 
oligomerization of Bak-Bax in the outer mitochondrial membrane is a CL 
dependent process, which permeabilizes the outer mitochondria to trigger Cyt c 
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release and progression of apoptosis (Liu et al., 2004; Sani et al., 2009). This 
suggests that CL-rich regions in the outer membrane serve as a key signal for 
targeting pro-apoptotic proteins of the Bcl2 family to bring about apoptosis (Lutter 
et al., 2000; Lutter et al., 2001).  
 iii) Translocation of CL. Early in apoptosis, CL translocation from the 
inner to the outer mitochondrial membrane may be carried out through several 
transport modes. First, CL is enriched at the inner and outer membrane contact 
sites, which are enriched in CL through interactions with mitochondrial creatine 
kinase (MtCK), could facilitate the transfer of CL from the inner to outer 
membrane (Epand et al., 2007a; Epand et al., 2007b; Maniti et al., 2009; 
Schlame and Augustin, 1985; Schlattner et al., 2004; Speer et al., 2005). 
Second, phospholipid scramblase-3 (PLS-3) has been shown to translocate CL 
from the inner membrane to the outer membrane during the onset of apoptosis 
(Liu et al., 2003a; Liu et al., 2003b; Van et al., 2007). Consistent with this, cells 
overexpressing PLS-3 exhibit increased apoptosis, while inactivation of PLS-3 
leads to increased resistance to UV-induced apoptosis (Liu et al., 2003b). CL and 
Bid interactions have been shown at the contact sites, which likely contribute to 
mitochondrial permeabilization to induce apoptosis (Kim et al., 2004). Changes in 
CL content in the membrane may be mediated by Bid, as evidence suggests that 
Bid exhibits lipid transfer activity (Esposti et al., 2001; Sorice et al., 2004). 
Lymphoblastoid cells derived from BTHS and TAZ knockdown HeLa cells were 
more resistant to Fas-induced apoptosis (Gonzalvez et al., 2008). Specifically, 
reduction of mature CL caused defective activation of caspase-8, suggesting that 
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processing of caspase-8 on the mitochondrial membranes is CL-dependent. To 
summarize, CL in the mitochondria is an important mediator of apoptosis, and 
apoptotic proteins are directed to the mitochondria in a CL-dependent manner.  
 
4.  CL in bioenergetics and mitochondrial dysfunction 
The relationship between CL and ROS is complex. The important role of 
CL in mitochondrial bioenergetics suggests that CL deficiency may lead to an 
increase in ROS, which is generated in the mitochondria as a byproduct of 
oxidative phosphorylation (Barros et al., 2003; Grant et al., 1997; Pitkanen and 
Robinson, 1996). CL physically interacts with proteins of the mitochondrial 
respiratory chain complexes and other components of the membrane and forms 
lipid scaffolds for tethering and stabilizing mitochondrial membrane proteins to 
enhance their enzymatic activities (Beyer and Klingenberg, 1985; Beyer and 
Nuscher, 1996; Fry and Green, 1980; Fry and Green, 1981; Joshi et al., 2009; 
Sedlak and Robinson, 1999). Consistent with this role in bioenergetics, 
mitochondria deficient in CL exhibit decreased activity of respiratory complexes 
and carrier proteins (Claypool, 2009), and CL deficiency leads to an increase in 
ROS (Chen et al., 2008a). ROS, in turn, damages CL by peroxidation of the 
unsaturated fatty acids.  
 
i) CL and supercomplexes 
For efficient substrate channeling between the individual complexes, the 
mitochondrial respiratory chain components are organized in supramolecular 
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structures called supercomplexes (Schagger and Pfeiffer, 2000). In mammalian 
cells, complex I is associated with two units of complex III and multiple units of 
complex IV. In S. cerevisiae, which lacks complex I, two copies of complex III are 
bound to either one or two units of complex IV. CL deficiency in yeast leads to 
destabilization of the respiratory supercomplexes, indicating that CL functions to 
stabilize these complexes (Pfeiffer et al., 2003; Zhang et al., 2002a; Zhang et al., 
2005a). Similarly, tafazzin deficient human fibroblasts exhibit destabilization of 
the supercomplexes (McKenzie et al., 2006). For efficient ADP/ATP exchange, 
CL is also required for the association of the ADP/ATP carrier protein with the 
supercomplexes (Claypool et al., 2008).  
 
ii) CL deficiency and ROS generation. The role of CL in the 
supercomplexes may be that of a proton trap, to avoid leakage of protons and 
enhance the membrane potential for efficient oxidative phosphorylation (Haines 
and Dencher, 2002; Hoch, 1998; Jiang et al., 2000). CL may also reduce leakage 
of electrons, which can increase the generation of ROS. Not surprisingly, 
defective supercomplex formation and CL deficiency lead to increased ROS 
production (Chen et al., 2008a; Chen et al., 2012).  
Among the respiratory chain complexes, complexes I and III are prime 
sites for ROS generation (Barja, 1999; Grivennikova and Vinogradov, 2006; 
Kushnareva et al., 2002; Turrens et al., 1985). Because of the proximity of CL to 
these ROS generating centers, the unsaturated fatty acyl chains of CL are 
susceptible to damage by peroxidation. Superoxide generated by respiratory 
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complex III causes peroxidation of CL and alters the activity of Cyt c oxidase 
(Paradies et al., 2000; Paradies et al., 2001; Paradies et al., 1998). Optimal 
function of Cyt c oxidase, the terminal enzyme complex of the respiratory chain, 
is dependent on CL (Abramovitch et al., 1990; Fry et al., 1980; Powell et al., 
1987; Robinson et al., 1980). Reduced activity of Cyt c oxidase from reperfused 
heart was restored specifically by exogenous supplementation of CL, but not by 
peroxidized CL or other phospholipids (Paradies et al., 1999b). In addition, 
reduced activity and increased ROS generation by complexes I and III were also 
rescued by CL supplementation (Paradies et al., 2001; Petrosillo et al., 2007). 
These studies indicate that peroxidized CL cannot effectively carry out 
mitochondrial functions that are dependent on normal CL.  
Peroxidation of CL by ROS is seen as the primary cause of CL 
mobilization to the outer leaflet of the inner membrane. Human leukemia cells 
treated with the apoptosis-inducing drug staurosporine rapidly underwent 
apoptosis along with an increase in CL content in the outer mitochondrial 
membrane (Garcia Fernandez et al., 2002). However, the change in CL content 
was preceded by increased ROS production and CL peroxidation, suggesting 
that perturbation of CL metabolism could be an early step in mitochondria-
induced apoptosis. Due to the high content of unsaturated fatty acyl chains, CL is 
particularly susceptible to peroxidation (Ferlini et al., 1999; Ushmorov et al., 
1999). Peroxidation of CL alters the molecular conformation leading to formation 
of non-bilayer hexagonal structures, which could serve as a marker for targeting 
the cytosolic apoptotic machinery to the mitochondria (Aguilar et al., 1999). 
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iii) CL in mitochondrial dysfunction and aging. Under normal 
physiological conditions, the damaged fatty acyl chains of CL may be replaced 
through the remodeling process (Malhotra et al., 2009). Pathological remodeling 
of CL has been linked to mitochondrial dysfunction in human diseases (Han et 
al., 2007; Lee et al., 2006; Li et al., 2010; Saini-Chohan et al., 2009). As 
discussed above, loss of the CL remodeling enzyme tafazzin leads to BTHS. 
Recent studies have shown that ALCAT1 may be involved in the pathological 
remodeling of CL in cells undergoing oxidative stress. As mentioned earlier, 
ALCAT1 overexpression leads to a decrease in CL levels and aberrant 
remodeling of CL with long chain polyunsaturated acyl chains such as DHA, 
which are highly susceptible to oxidation by ROS (Hong et al., 2002; Li et al., 
2010; Watkins et al., 1998). The close proximity of CL to respiratory complexes in 
the inner membrane where ROS is generated increases exposure of these long 
chain unsaturated fatty acyl chains to ROS. Aberrant CL remodeling resulting 
from increased ALCAT1 expression leads to the mitochondrial dysfunction seen 
in pathological conditions such as hyperthyroid cardiomyopathy, diabetes, and 
diet-induced obesity in mice (Cao et al., 2009; Li et al., 2012; Li et al., 2010; Liu 
et al., 2012). ALCAT1 null mice exhibit increased expression of MLCAT1 along 
with elevated levels of CL containing linoleic acid. These findings underscore the 
significance of CL remodeling and the impact of this process on mitochondrial 
function and ROS generation. 
A decline in CL levels appears to be a primary feature of aging (Lenaz et 
al., 1997; Lewin and Timiras, 1984; Maftah et al., 1994; Paradies and Ruggiero, 
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1990; Paradies et al., 1993; Paradies et al., 1997). In aging cells, CL is 
pathologically remodeled with polyunsaturated fatty acyl chains such as 
arachidonic and docosahexaenoic acids, which are more susceptible to 
peroxidation than linoleic acid in normal CL (Lee et al., 2006; Sparagna and 
Lesnefsky, 2009).  Mitochondrial CL levels, along with oxidative capacity and 
ATP synthesis, decrease significantly with age (Hagen et al., 1998a; Hoch, 1992; 
Maftah et al., 1994; Sen et al., 2007; Sen et al., 2006). 
CL is required for the optimal function of several mitochondrial carrier 
proteins involved in the transport of essential metabolites into mitochondria 
(Claypool, 2009). In the heart, oxidation of pyruvate and β-oxidation of fatty acids 
are two major sources of ATP generation (Christe and Rodgers, 1994; Davila-
Roman et al., 2002; Wisneski et al., 1985). The transport of pyruvate into 
mitochondria by the pyruvate carrier and the exchange of carnitine esters by the 
carnitine:acylcarnitine translocase are, therefore, critical for energy metabolism. 
Studies have demonstrated that enzymatic activities of both the mitochondrial 
pyruvate carrier and carnitine:acylcarnitine translocase, which are dependent on 
CL (Nalecz et al., 1986; Noel and Pande, 1986), are decreased in aging heart 
muscle (Paradies et al., 1999a; Paradies et al., 1995). Interestingly, 
administration of acetyl-L-carnitine in aged rats restored decreased CL levels and 
the activities of the mitochondrial pyruvate carrier and carnitine:acylcarnitine 
translocase to levels found in young rats (Paradies et al., 1999a; Paradies et al., 
1995). Dietary supplementation of acetyl-L-carnitine also showed similar 
beneficial effects, increasing mitochondria membrane potential and, in turn, 
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improving physical mobility in aged rats (Hagen et al., 1998a; Hagen et al., 
1998b). These findings suggest that the supply of carnitine to the mitochondria 
may become limited during aging, hindering energy production through β-
oxidation (Maccari et al., 1990; Paradies et al., 1995). Although acetyl-L-carnitine 
supplementation restored CL levels and improved mitochondrial metabolic 
functions in aged animals, the underlying molecular mechanism remains 
unresolved. 
 
5.  CL and the PKC-Slt2 cell integrity pathway:  
Null mutants in yeast have been characterized for each step of the CL 
biosynthetic pathway, and mutants blocked earlier in the pathway have more 
severe phenotypes.  Thus, the pgs1Δ mutant, which cannot synthesize CL or the 
precursor PG (Fig. 1.1), exhibits severe growth defects not only in non-
fermentable carbon sources, which are metabolized by respiration, but also in 
fermentable carbon sources, in which respiration is not required (Chang et al., 
1998a; Dzugasova et al., 1998). This observation indicated that PG and/or CL 
are required for cellular functions apart from mitochondrial bioenergetics (Jiang et 
al., 1999). Genetic studies to isolate spontaneous suppressors of the pgs1Δ 
mutant growth defect identified a loss of function mutation of KRE5, a gene 
involved in cell wall biogenesis (Zhong et al., 2005). Consistent with defective cell 
wall biogenesis, the pgs1Δ mutant exhibited enlarged cell size characteristic of 
cell wall mutants, reduced levels of β-1,3-glucan as a result of decreased activity 
of glucan synthase, and sensitivity to cell wall perturbing agents (de Nobel et al., 
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2000; Popolo et al., 1993; Zhong and Greenberg, 2005).  These defects were 
restored by disruption of KRE5 in pgs1Δ, which increased expression of the 
genes FKS1 and FKS2 encoding glucan synthase (Zhong et al., 2007). These 
findings were in agreement with the identification of PGS1 in a screen to identify 
genes involved in cell wall biogenesis (Lussier et al., 1997). 
Studies to gain insight into the mechanism linking CL to the cell wall 
focused on the PKC-Slt2 cell integrity pathway. Activation of the cell integrity 
pathway is triggered by signals generated from cell wall sensor proteins to Rom2, 
which, in turn, activates formation of the GTP-bound form of Rho1p. The 
activated Rho1 protein transmits a signal to Pkc1 to trigger the Mpk1/Slt2 MAPK 
signaling cascade, which results in dual phosphorylation of Slt2 (Heinisch et al., 
1999; Levin, 2005). The dual phosphorylation of Slt2 is essential to activate 
transcription factors that up-regulate genes involved in cell wall remodeling, 
particularly in response to heat stress (de Nobel et al., 2000; Jung and Levin, 
1999; Terashima et al., 2000). The pgs1Δ mutant exhibited defective activation of 
the PKC-Slt2 cell-integrity signaling cascade, indicated by decreased Slt2 
phosphorylation levels (Zhong et al., 2007). Consistent with this, overexpression 
of individual genes in the PKC- Slt2 pathway rescued the growth defect of pgs1Δ 
at elevated temperature and improved resistance to the cell wall perturbing 
chemicals calcofluor white and caffeine. Interestingly, deletion of KRE5 in pgs1Δ 
also led to increased activation of the PKC-Slt2 cell-integrity pathway. 
 A mitochondrial connection to the cell wall is not new. Genome-wide 
screens have identified several yeast genes required for mitochondrial function 
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that, when mutated, affect chemical components of the cell wall (Conde et al., 
2003; Lussier et al., 1997; Page et al., 2003). Furthermore, mitochondrial 
respiratory defects negatively impact the synthesis of cell wall components 
(Lussier et al., 1997; Page et al., 2003). The underlying mechanism whereby CL 
regulates cell wall remodeling is not known. One possibility is that CL is required 
for activity of one or more proteins that exhibit dual localization in the cell 
wall/plasma membrane and mitochondria (Velours et al., 2002). Interesting 
possibilities include three proteins of the PKC-Slt2 cell integrity pathway, Fks1, 
Zeo1 and Rho1, which are found both in the mitochondria and the plasma 
membrane (Green et al., 2003; Sickmann et al., 2003; Zahedi et al., 2006). 
Mitochondrial targeting of these proteins may be CL-dependent. Alternatively, 
their stability in the mitochondrial membrane may be decreased in the absence of 
CL. 
 The yeast cell wall also plays an important role in regulating replicative life 
span (Kaeberlein and Guarente, 2002).  Consistent with this, the pgs1Δ mutant, 
which exhibits cell wall defects, also has a decreased replicative life span (Zhong 
et al., 2005; Zhou et al., 2009). Intriguingly, experiments to elucidate the 
mechanism linking PG/CL to defects in the cell wall, PKC/Slt2 signaling and 
aging led to another signaling pathway – the HOG stress response pathway. 
 
6.  CL and the HOG stress response pathway: 
 In response to stress, cells are regulated by the opposing actions of the 
PKC-Slt2 and HOG signaling pathways (Hahn and Thiele, 2002; Hayashi and 
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Maeda, 2006; Winkler et al., 2002). Heat or low osmolarity stress leads to 
activation of the PKC-Slt2 pathway, resulting in increased expression of the cell 
wall remodeling genes leading to a decrease in turgor pressure (Davenport et al., 
1995; Garcia-Rodriguez et al., 2005; Hohmann, 2002). In contrast, activation of 
the HOG signaling pathway causes an increase in turgor pressure (Hohmann, 
2002; Rep et al., 2000). Because the pgs1Δ mutant exhibited defective activation 
of the PKC-Slt2 signaling cascade, it was hypothesized that growth defects of the 
mutant resulted from increased turgor pressure, which may be rescued by down-
regulation of the HOG pathway (Fig. 1.3) (Zhou et al., 2009). This hypothesis 
was supported by the finding that deletion of SHO1, an upstream activator of 
HOG signaling, rescued growth defects, increased the replicative life span, and 
alleviated sensitivity to cell wall perturbing agents in pgs1Δ (Zhou et al., 2009). 
Interestingly, the mutant did not exhibit increased activation of the HOG pathway. 
It is possible that, in the absence of PKC-Slt2 activation, even wild type levels of 
HOG activation lead to turgor pressure levels that affect growth. These findings 
suggest that homeostasis achieved by these two signaling pathways is perturbed 
upon CL deficiency (Fig. 1.3).  
 
7.  CL mediates cross-talk between mitochondria and vacuole: 
 The yeast crd1Δ mutant, which lacks CL, was shown to have defective 
vacuolar function (Chen et al., 2008b). CL deficiency caused decreased V-
ATPase activity and proton pumping, reduced vacuolar acidification, and 
enlargement of the vacuole. The yeast vacuole plays a crucial role in adjusting to 
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Figure 1.3. CL deficiency leads to perturbation of PKC-Slt2 and HOG 
signaling pathways. The PKC-Slt2 and HOG signaling pathways coordinately 
regulate cell wall biogenesis and intracellular turgor pressure, respectively. Under 
hypertonic or cold stress conditions, extracellular osmolarity is increased, 
causing an efflux of intracellular water to reduce the turgor pressure on the cell 
wall. To counteract augmented extracellular osmolarity, the HOG pathway is 
activated, which leads to an increase in intracellular turgor pressure. In contrast, 
under heat or hypotonic stress, extracellular osmolarity is decreased, which 
causes an influx of water inside the cell to increase intracellular turgor pressure. 
To counteract the increased turgor pressure, the activated PKC-Slt2 pathway 
induces cell wall synthesis. We hypothesize that disruption of the CL pathway by 
mutation of PGS1 generates a signal that is detected by regulators or 
components of the PKC-Slt2 pathway, which, in turn, down-regulates the 
pathway. Under these conditions, an increase in intracellular turgor pressure by 
activation of the HOG pathway is deleterious in pgs1Δ cells.  
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high external osmolarity and decreased turgor pressure, and in maintaining 
cytosolic ion concentrations (Klionsky et al., 1990; Latterich and Watson, 1993). 
Consistent with perturbation of intracellular osmotic balance in the crd1Δ mutant, 
growth and vacuolar defects were rescued by supplementation of sorbitol (Chen 
et al., 2008b).  
 In some genetic backgrounds, the crd1Δ mutant exhibits increased 
expression of RTG2, a critical sensor of mitochondrial dysfunction that relays 
metabolic defects to the nucleus via the retrograde signaling pathway (Butow and 
Avadhani, 2004; Liu and Butow, 2006). Consistent with overactivation of Rtg2, 
deletion of the RTG2 gene restored vacuolar acidification and V-ATPase activity 
and rescued the growth defect of the crd1Δ mutant at elevated temperature. 
However, deletion of the retrograde pathway activator RTG3 did not rescue the 
mutant, suggesting that the defects observed in crd1Δ resulted from Rtg2 
functions unrelated to retrograde activation. 
 One possible explanation for the vacuolar defects in crd1Δ is that the loss 
of CL leads to intracellular osmotic imbalance, as suggested by the enlarged cell 
size of the mutant (Fig. 1.4). Consistent with this, deletion of the NHX1 gene (but 
not any of the other vacuole ion transporters) in crd1Δ restored vacuolar 
morphology to wild type levels (Chen et al., 2008b). Nhx1 is the Na+/H+ 
exchanger located in late endosomal/prevacuolar membranes, and is involved in 
the export of protons in exchange for cytosolic Na+ or K+ (Ali et al., 2004; Brett et 
al., 2005). 
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Figure 1.4. Proposed models to explain the role of CL in vacuolar function. 
It is likely that CL is transported to the vacuole through mitophagy, the selective 
degradation of mitochondria via the autophagosome, which delivers its cargo to 
the vacuole. (A) Under normal physiological conditions, CL may provide stability 
to the V-ATPase, which is essential to maintain its activity. (B) CL deficiency may 
lead to perturbation of mitophagy, which results in decreased delivery of CL to 
the vacuole and, subsequently, to destabilization of the V-ATPase, decreased 
ATPase activity, and enlargement of the vacuole.  
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Another possibility is that CL may regulate vacuolar function by directly 
activating the V-ATPase (Fig. 1.4). While CL is predominantly found in the 
mitochondrial membranes, significant amounts are also detected in the vacuolar 
membrane, and the levels vary depending on the carbon source of the growth 
media (Zinser et al., 1991). How does CL, which is synthesized in the 
mitochondria, get to the vacuole? The most likely mechanism is via selective 
degradation of the mitochondria by the autophagic process known as mitophagy, 
which is strongly induced in yeast by nutrient starvation and during the stationary 
growth phase (Kanki et al., 2009; Komatsu et al., 2005; Lemasters, 2005; 
Shintani et al., 2002; Takeshige et al., 1992; Tal et al., 2007). CL that has 
integrated into the vacuolar membrane as a result of mitophagy may directly 
activate the V-ATPase and/or stabilize the protein. This possibility is highly 
speculative at this stage, as such interactions have not yet been reported. 
 Cross-talk between mitochondria and vacuole is further supported by a 
recent finding, which showed that the vacuolar pH is a determinant of 
mitochondrial function and aging in yeast cells (Hughes and Gottschling, 2012). 
Aging yeast cells exhibit a decline in vacuolar acidity, which causes mitochondrial 
dysfunction and a decrease in replicative life-span (Hughes and Gottschling, 
2012). Consistent with this, enhancing vacuolar acidity by overexpressing VMA1 
or VPH2, which encode proteins that regulate V-ATPase activity, suppressed 
mitochondrial dysfunction. The mechanisms underlying the interplay between 
vacuole and mitochondria, and the role of CL in this process, remain to be 
elucidated. 
 25 
 
8.  CL and iron homeostasis: 
 In addition to the cellular functions mentioned above, our recent studies, 
which are the focus of this dissertation, suggest that CL is required for 
maintaining mitochondrial and cytosolic iron homeostasis (Patil et al., 2012). Iron 
is an essential metal that is utilized for the synthesis of two crucial cellular 
components, heme and iron-sulfur (Fe-S) clusters (Kaplan et al., 2006; Ye and 
Rouault, 2010). Both heme and Fe-S clusters are incorporated into proteins that 
participate in cellular functions that include respiration, DNA replication, and 
synthesis of cholesterol and amino acids (Philpott et al., 2012; Shakoury-Elizeh 
et al., 2010).  
 Iron exists in two oxidation states; in the ferric (Fe3+) form it is insoluble 
whereas in the ferrous (Fe2+) form it is highly reactive. While sufficient iron is 
essential, excess iron is extremely toxic (Hentze et al., 2004). Therefore, cellular 
iron must be constantly chaperoned, and its acquisition and transport tightly 
regulated. To acquire iron, yeast employs high and low affinity iron uptake 
systems, which are collectively referred, the iron regulon (Kosman, 2003). 
Expression of the iron regulon is controlled by the iron-responsive transcription 
factors Aft1 and its paralogue, Aft2 (Rutherford and Bird, 2004; Rutherford et al., 
2003; Yamaguchi-Iwai et al., 1995). Aft1 and Aft2 are the direct sensors of 
mitochondrial Fe-S biogenesis, and they respond to iron deficiency or impairment 
of mitochondrial Fe-S clusters by up-regulating the iron regulon, which leads to 
an increase in iron-uptake (Hausmann et al., 2008; Kaplan et al., 2006). 
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 Fe-S cluster biogenesis in the mitochondria occurs via a complex pathway 
composed of two stages (Rawat and Stemmler, 2011). First, Fe-S clusters are 
assembled on the Isu scaffold, process in which iron (Fe) is delivered by Yfh1 
and sulfur (S) is provided by the Nfs1-Isd11 complex. Second, the 2Fe-2S 
clusters formed on Isu1 are transferred to apoenzymes to form holoenzymes by 
a process catalyzed by Ssq1/Grx5/Jac1/Mge1 proteins.  
 The optimal function of several mitochondrial Fe-S proteins, including 
aconitase and succinate dehydrogenase of the TCA cycle and respiratory 
complex III, depends on Fe-S biogenesis (Gerber et al., 2004; Lange et al., 2000; 
Muhlenhoff et al., 2002). Similarly, mitochondrial Fe-S biogenesis is also required 
for the maturation of cytosolic Fe-S proteins, as cytosolic Fe-S assembly 
depends on Fe-S co-factors synthesized in the mitochondria (Gerber et al., 2004; 
Lange et al., 2000; Muhlenhoff et al., 2002). Perturbations of mitochondrial Fe-S 
biogenesis also lead to defective maturation of cytosolic Fe-S proteins. The 
studies described in chapter two demonstrate that CL deficiency leads to 
perturbation of mitochondrial Fe-S biogenesis, which results in decreased activity 
of both mitochondrial and cytosolic Fe-S proteins. 
 
9.  Project outline: 
 
Although disruption of CL synthesis due to mutations in tafazzin leads to 
BTHS, it is unclear how CL deficiency contributes to the pathology observed. As 
discussed above, studies primarily in yeast have enhanced our understanding of 
the cellular role of CL. Yet, very little is known of the biochemical processes that 
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are disrupted in BTHS patients. To gain insight into CL functions that might 
explain the pathology and the variable clinical phenotypes observed in BTHS, 
genome-wide expression profiling was carried out in the yeast CL mutant crd1Δ. 
The most intriguing finding in this study was increased expression of the iron 
uptake genes in the mutant, suggesting either iron deficiency or perturbation of 
processes involving mitochondrial Fe-S cluster biogenesis and/or export of extra-
mitochondrial Fe-S co-factors.  
The data presented in chapter two demonstrates that CL deficiency leads 
to perturbation of iron homeostasis due to defective Fe-S cluster biogenesis in 
the mitochondria. As an indication of this, the crd1Δ mutant exhibits elevated 
mitochondrial iron levels along with decreased activity of enzymes that contain 
Fe-S clusters. The synthetic genetic interaction of crd1Δ with the mitochondrial 
Fe-S scaffolding protein Isu1 suggests that the underlying mechanism for 
perturbation of iron homeostasis is defective synthesis of Fe-S clusters. These 
findings suggest that iron homeostasis could be an important physiological 
modifier that contributes to the phenotypes observed in BTHS patients. 
Because the synthesis of several amino acids is dependent on Fe-S 
enzymes, perturbation of Fe-S biogenesis would be predicted to cause amino 
acid deficiencies. The data presented in chapter three show that a decrease in 
the activities of Fe-S enzymes aconitase and sulfite reductase in crd1Δ leads to 
auxotrophies for both glutamate and cysteine. Interestingly, these two amino 
acids are required for the synthesis of an essential antioxidant, glutathione 
(GSH), a tripeptide of glutamate, cysteine, and glycine. Consistent with 
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decreased synthesis of GSH, the growth defect of crd1Δ at elevated temperature 
is rescued by GSH supplementation. These findings suggest that the underlying 
mechanism for GSH deficiency in crd1Δ is defective mitochondrial Fe-S 
biogenesis, which results in depletion of precursors for GSH synthesis. 
In order to identify the cellular functions that are perturbed in the absence 
of CL, a screen of suppressors of the crd1Δ mutant was carried out, which is 
described in chapter four. Briefly, the yeast genomic DNA library was 
overexpressed in crd1Δ to identify genes that restore the growth of crd1Δ at 
elevated temperature. In this screen, 50 putative suppressors of crd1Δ were 
obtained. Interestingly, one of the suppressor genes was LEU2, which encodes 
an enzyme involved in leucine biosynthesis, a process that is perturbed in crd1Δ 
(described in chapter two). This supports the finding that perturbation of leucine 
synthesis likely contributes to the growth defect of crd1Δ. 
Although the data presented in this thesis describe new cellular functions 
of CL, the mechanism underlying the role played by CL in these processes 
remains to be answered. These questions and future studies are described in 
chapter five. 
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CHAPTER 2 
 
LOSS OF CARDIOLIPIN LEADS TO PERTURBATION OF MITOCHONDRIAL 
AND CELLULAR IRON HOMEOSTASIS 
The work described in this chapter has been published in the Journal of 
Biological Chemistry, 288(3): 1696-1705, 2013.  
INTRODUCTION 
 
Cardiolipin (CL) is a structurally and functionally unique phospholipid that 
is almost exclusively present in mitochondrial membranes (Schlame and Ren, 
2009; Schlame et al., 2000). The presence of CL is critical for maintaining 
mitochondrial function, structure, and membrane fluidity. Perturbation of CL 
synthesis alters mitochondrial bioenergetics, resulting in reduced membrane 
potential, inefficient coupling of respiration, and decreased ATP synthesis 
(Claypool et al., 2008; Jiang et al., 2000; Koshkin and Greenberg, 2000; Koshkin 
and Greenberg, 2002). In the inner membrane, CL is tightly associated with 
several proteins in respiratory complexes I, III, and IV (Joshi et al., 2009). CL is 
essential for the stability of respiratory chain supercomplexes which, in yeast, are 
comprised of dimeric ubiquinol-cytochrome c oxidoreductase (complex III) and 
one or two complexes of cytochrome c oxidase (complex IV) (Cruciat et al., 2000; 
Pfeiffer et al., 2003; Zhang et al., 2002b). Perturbation of CL synthesis due to 
mutations in the CL remodeling enzyme tafazzin causes the severe human 
genetic disorder known as Barth syndrome (BTHS) (Bione et al., 1996b).  
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Tafazzin (Taz1) deficiency in yeast leads to biochemical and bioenergetic defects 
similar to those seen in BTHS patients (Brandner et al., 2005; Gu et al., 2004; Ma 
et al., 2004; McKenzie et al., 2006). 
While perturbation of CL synthesis due to loss of tafazzin leads to cardio- 
and skeletal myopathy, neutropenia, and growth retardation in BTHS (Barth et 
al., 1999b),  the clinical presentation of this disorder is highly variable, ranging 
from neonatal death to lack of clinical symptoms (Barth et al., 1999b; Bleyl et al., 
1997). In order to gain insight into CL functions that might explain the pathology 
and variable phenotypes observed in BTHS, we carried out a genome-wide 
expression analysis in the yeast CL mutant crd1Δ, which lacks CL synthase. The 
most striking alterations in gene expression were observed in iron uptake genes. 
These genes encode components of the yeast high- and low-affinity iron uptake 
systems, collectively referred to as the iron regulon (Kosman, 2003). Because 
the gene expression analyses indicating elevated expression of the iron regulon 
were carried out in iron-replete conditions, we hypothesized that CL might be 
required for mitochondrial Fe-S biogenesis and/or export of mitochondrial Fe-S 
co-factors to the cytosol, two processes known to induce upregulation of the iron 
regulon (Hausmann et al., 2008; Rutherford et al., 2005). 
The assembly of Fe-S clusters from ferrous (Fe2+) and sulfide (S2-) ions 
does not occur spontaneously in living cells, as unchaperoned iron and sulfur are 
toxic. Rather, cells utilize a complex Fe-S assembly and transport process that is 
highly conserved from yeast to humans (Lill and Muhlenhoff, 2006). The 
assembly of Fe-S clusters in the mitochondria begins on the highly conserved 
 31 
 
scaffolding protein Isu1 and its homolog Isu2 (Muhlenhoff et al., 2003). The Nfs1-
Isd11 complex delivers sulfur (Muhlenhoff et al., 2004; Zheng et al., 1994), and 
Yfh1 donates iron (Fe2+) to the Isu scaffold (Zhang et al., 2006). This process 
also includes ferredoxin (Arh1) and ferredoxin reductase (Yah1), which provide 
electrons for the reduction of sulfur to sulfide (Lange et al., 2000; Li et al., 2001). 
The Fe-S clusters assembled on the scaffold are transferred to the recipient 
apoproteins, in a process that is assisted by several proteins localized in the 
mitochondrial matrix (Lill and Muhlenhoff, 2006).  
Mitochondria also possess Fe-S export machinery, which transports an 
unknown Fe-S component from the mitochondria that is matured by the cytosolic 
machinery into 4Fe-4S clusters (Kispal et al., 1999; Lange et al., 2001b; Rissler 
et al., 2005). The mitochondrial Fe-S export machinery includes the ABC 
transporter Atm1 in the inner membrane and the sulfhydryl oxidase Erv1 in the 
intermembrane space. Perturbations in mitochondrial Fe-S assembly or Fe-S 
export machinery are known to induce expression of the Aft1/Aft2-regulated iron 
uptake genes, leading to increased mitochondrial iron levels. Defects in 
mitochondrial Fe-S assembly lead to decreased maturation of both mitochondrial 
and cytosolic Fe-S proteins (Gerber et al., 2004; Hausmann et al., 2008; Kaut et 
al., 2000; Kispal et al., 1999; Li et al., 1999; Muhlenhoff et al., 2002). In addition, 
excess mitochondrial iron causes oxidative damage to Fe-S clusters due to the 
formation of reactive oxygen species (ROS) (Bulteau et al., 2007; Moreno-
Cermeno et al., 2010; Vasquez-Vivar et al., 2000).  
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In the current study, we show that crd1Δ cells exhibit perturbations in iron 
homeostasis, including increased expression of the iron uptake genes, elevated 
mitochondrial iron levels, and growth sensitivity to both FeSO4 supplementation 
and the ROS inducing agent H2O2. We further demonstrate that the loss of CL 
leads to decreased activities of both mitochondrial and cytosolic Fe-S enzymes, 
suggesting that the mechanism underlying altered iron homeostasis is 
perturbation of Fe-S biogenesis. Consistent with this conclusion, crd1Δ cells 
exhibit a synthetic genetic interaction with the Fe-S scaffolding protein Isu1. 
Additionally, the iron homeostasis defects in crd1Δ are not rescued by 
overexpression of ATM1, the major component of mitochondrial Fe-S export 
machinery, which is activated by CL (36), nor is it rescued by overexpression of 
YAP1, which regulates expression of antioxidant genes (Inoue et al., 1999; Lee 
et al., 1999; Sugiyama et al., 2000). Overexpression of ATM1 and YAP1 might 
reasonably be expected to overcome defective Fe-S cluster export from 
mitochondria. However, overexpression did not rescue the mutant defects, 
suggesting that the loss of CL affects the process of mitochondrial Fe-S 
biogenesis. This study is the first to demonstrate that CL is required for Fe-S 
cluster biogenesis and for the maintenance of mitochondrial and cellular iron 
homeostasis. 
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MATERIALS AND METHODS 
 
Yeast strains and growth media 
 The yeast Saccharomyces cerevisiae strains used in this work are listed in 
Table 1. Synthetic defined (SD) medium contained adenine (20.25 mg/l), arginine 
(20 mg/l), histidine (20 mg/l), leucine (60 mg/l), lysine (20 mg/l), methionine (20 
mg/l), threonine (300 mg/l), tryptophan (20 mg/l), and uracil (20 mg/l), yeast 
nitrogen base without amino acids (Difco, Detroit, MI), and carbon source 
(fermentative) glucose (2%) or (respiratory) glycerol (3%) plus ethanol (0.65%) or 
(respiro-fermentative) galactose (2%). SD-drop out medium contained all of the 
above-mentioned ingredients except for the indicated amino acid. For growth 
experiments on excess iron, 1 µM CuSO4 was used and FeSO4 was solubilized 
in 0.1 N HCl, filter-sterilized and added to the culture medium at the indicated 
concentration. Complex media (YPD or YP-gal) contained yeast extract (1%), 
peptone (2%), and either glucose (2%) or galactose (2%) as indicated. 
 Deletion mutants were constructed by replacing the entire open reading 
frame of the target gene with the KanMX4 cassette by homologous 
recombination. The KanMX4 cassette was amplified from the pUG6 plasmid 
using primers consisting of 51 nucleotides identical to the target gene flanking 
regions at the 5’ end and 21 nucleotides for the amplification of the KanMX4 
gene at the 3’ end. The PCR product was transformed by electroporation into 
cells, and transformants were selected on YPD media containing G418 (300 
µg/ml). Disruption of the target gene was confirmed by PCR using primers  
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Table 2.1. Yeast strains and plasmids used in this study. 
  
Strain Genotype Source or reference 
FGY3 MATa, ura3-52, lys2-801, ade2-101, trp1-Δ1, his3-
Δ200, leu2-Δ1 
(Jiang et al., 1997) 
FGY2 MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1, 
his3-Δ200, leu2-Δ1, crd1Δ::URA3 
(Jiang et al., 1997) 
FGY3 isu1Δ MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1, 
his3-Δ200, leu2-Δ1, isu1Δ::KanMX4 
This study 
FGY2 isu1Δ MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1, 
his3-Δ200, leu2-Δ1, crd1Δ::URA3, 
isu1Δ::KanMX4 
This study 
FGY3 isu2Δ MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1, 
his3-Δ200, leu2-Δ1, isu2Δ::KanMX4 
This study 
FGY2 isu2Δ MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1, 
his3-Δ200, leu2-Δ1, crd1Δ::URA3, 
isu2Δ::KanMX4 
This study 
pCM182 Low-copy number plasmid, TRP1 nutritional 
marker 
ATCC® Number: 
87656 
pCM182-
ISU1 
Derivative of pCM182, expresses ISU1 from the 
TETOFF promoter 
This study 
pRS415 Low-copy number plasmid, LEU2 nutritional 
marker 
(Zhong et al., 2004) 
YEp351 High-copy number plasmid, LEU2 nutritional 
marker 
(Hill et al., 1986) 
YEp351-
YAP1 
Derivative of YEp351, expresses YAP1 from the 
native promoter 
(Wemmie et al., 1994) 
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against the target gene coding sequences. 
 
Plasmid construction and cloning 
To construct the ISU1-overexpressing plasmid, a 538-bp sequence 
containing the entire open reading frame of ISU1 was amplified from yeast 
genomic DNA using BamHI-tagged primer ISU1-BamHIF (5-
GGAAAACACAACGGATCCCACATATTTAACC-3) and PstI-tagged primer ISU1-
PstIR (5-GATCTTGTTCTGCAGCCGGTTATCTTCTT-3). Similarly, a 2098 bp 
sequence containing the entire open reading frame of ATM1 was amplified using 
NotI-tagged primer ATM1-NotIF (5-
TTGATAGATGCGGCCGCAACCTGCAAATG-3) and PstI-tagged primer ATM1-
PstIR (5-TACATGTCTGCAGCAATATTTACTTACGAGCG-3). The PCR products 
were ligated to pCM182 (a low-copy number plasmid with selectable marker 
TRP1) downstream of the TETOFF promoter. All the plasmids were amplified and 
extracted using standard protocols. The plasmids were transformed into yeast 
strains using the yeast one-step transformation protocol (Chen et al., 1992). A 
high-copy number YEp351-YAP1 overexpression plasmid was a kind gift from W. 
Scott Moye-Rowley (Univ. of Iowa) (Wemmie et al., 1994). 
 
Microarray analysis  
Yeast cells were grown to the early stationary phase in YPD, and total 
RNA was isolated by hot phenol extraction (Kohrer and Domdey, 1991). RNA 
was further purified using an RNeasy kit from Qiagen. Yeast 6.4k microarray 
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slides containing 6240 different yeast expressed sequence tags (double spotted) 
were purchased from University Health Network (Toronto, M5G 2C4). Synthesis 
of Cy3- or Cy5-labeled cRNA and hybridization were performed using SlideHyb 
#1 buffer (Ambion) at the Research Technology Support Facility at Michigan 
State University (East Lansing, MI). The glass slides were scanned with an 
Affymetrix 428 Array Scanner and quantified using GenePix Pro 3.0 software 
(Axon). Array normalization and statistical analysis were performed using the 
“limma: Linear Models for Microarray Data” library module (version 2.2.0) of the 
R statistical package (version 2.2.0) (R_Development_Core_Team, 2005; Smyth, 
2005; Smyth, 2004; Smyth et al., 2005; Smyth and Speed, 2003). Slide intensity 
data was normalized using the global loess method. The least squares method 
was used for the linear model fit utilizing the Benjamini and Hochberg method to 
control the false discovery rate. Each experiment was repeated once with 
switched Cy3- and Cy5-labeling. The average of the 4 signal log ratios of each 
gene was computed and converted to a fold change. The raw data can be 
downloaded from the Gene Expression Omnibus 
(http://www.ncbi.nlm.nih.gov/geo, GPL3464). 
 
Quantitative PCR (qPCR) analysis  
 Yeast cultures (10 ml) were grown to the logarithmic growth phase, cells 
were harvested, and total RNA was isolated using the RNeasy Plus Mini kit from 
Qiagen. The cDNAs were synthesized with Transcriptor First Strand cDNA 
Synthesis Kit (Roche Diagnostics), and quantitative PCR reactions were 
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performed in a 25-µl volume using Brilliant™ SYBR® Green QPCR Master Mix 
(Stratagene) in a 96-well plate. Duplicates were included for each reaction. The 
primers used for qPCR are listed in Table 2.2. ACT1 was used as the internal 
control, and the RNA level of the gene of interest was normalized to ACT1 levels. 
PCR reactions were initiated at 95°C for 10 min for denaturation followed by 40 
cycles consisting of 30 s at 95°C and 60 s at 55°C. 
 
Biochemical assays and measurement of mitochondrial metal ion content  
Mitochondria were isolated from cell lysates prepared as previously 
described (Diekert et al., 2001). Briefly, spheroplasts obtained by zymolase 
treatment were disrupted by Dounce homogenization, and mitochondria were 
isolated by differential centrifugation. Total protein concentration was determined 
with a Bradford assay kit (BioRad), with BSA as the standard. The following 
assays were performed in isolated mitochondria. Succinate dehydrogenase 
activity was assayed by determining succinate-dependent reduction of 2,6-
dichlorophenol-indolphenol (DCPIP). The absorbance decrease at A600 was 
recorded as a reporter of decylubiquinone reduction (Pierik et al., 2009). 
Ubiquinol-cytochrome c oxidoreductase activity was assayed by monitoring 
reduction of cytochrome c at A550 (Atkinson et al., 2011). 
Cell extracts were prepared by resuspending cells in 500 µl TNTEG buffer 
(10 mM Tris-Cl pH 7.4, 2.5 mM EDTA, 150 mM NaCl, 10% v/v glycerol, 0.5% v/v 
Triton X-100) and subjecting them to mechanical breakage with glass beads. Cell   
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Table 2.2. Primers used for qPCR analyses. 
 
 
Gene Primer Sequence 
ACT1 Forward TCGTGCTGTCTTCCCATCTATCG 
Reverse CGAATTGAGAGTTGCCCCAGAAG 
AFT1 Forward ATGCATCTAAAAGGCCATGC 
Reverse ACTGGCTTTTCGGTTTCCTT 
FIT1 Forward CCACCTCCTCTGAGTCAAGC 
Reverse CAGATTGGGCATCCCTAGAA 
FIT2 Forward ACAAAGGTTGTCACCGAAGG 
Reverse TGAACCTGAACCGTTTGTCA 
FIT3 Forward GCTACATCCTCTAGCACCGC 
Reverse GCACCCATCAAACCAGTACC 
FET3 Forward ACAGTTTCGATCCGGACAAC 
Reverse CACCTGGGTTATCGGCTTTA 
FTR1 Forward GATTCAACCTTGCCAGTGGT 
Reverse ATTGTCCAGTTCTGGGTTGC 
ARN1 Forward CTCGCGATCCTGTTAAGGAG 
Reverse GGGAGACCATATGAGTCGGA 
ARN2 Forward TGTGGGACTTGTCGGTGTTA 
Reverse GGGCCATGAAGGTATCAATG 
ARN3 Forward TGGATTAGCGGGAACGTAAC 
Reverse GGAATACAAGCTAGCGGCAG 
  
 39 
 
debris and unbroken cells were separated by low speed centrifugation (2000 g 
for 5 min at 4 °C). The obtained supernatant was further centrifuged at 13,000 g 
for 10 min and the resulting supernatant was transferred to a new tube. Total 
protein concentration was determined as mentioned above. The following 
enzyme assays were performed in whole-cell extracts. Aconitase was assayed 
by the aconitase-isocitrate dehydrogenase coupled assay, in which NADPH 
formation was monitored at A340 (Pierik et al., 2009). Sulfite reductase was 
assayed by monitoring methylene blue formation at A670 from sulfide produced by 
NADPH-dependent sulfite reduction (Pierik et al., 2009; Rutherford et al., 2005). 
Isopropylmalate isomerase was assayed by monitoring formation of 
isopropylmalate at A235 from dehydration of 3-isopropylmalate (Pierik et al., 
2009). Statistical significance of all enzyme assay results was determined by an 
analysis of variance (ANOVA) and Bonferroni's posthoc test in KaleidaGraph. In 
the isopropylmalate isomerase assay, because the parental strains carry the 
leu2Δ null mutation, cells were transformed with a low/single copy pRS415 
plasmid containing the LEU2 marker.  
For the measurement of mitochondrial iron content, mitochondria were 
further purified via ultracentrifugation through a discontinuous Histodenz (Sigma-
Aldrich) gradient (14% and 22%). Mitochondria (0.25 mg mitochondrial protein) 
were digested in 70% HNO3 by boiling for 2 min and then diluted to 30% HNO3. 
Iron content was determined using an inductively coupled plasma-optical 
emission spectrometer (ICP-OES). 
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RESULTS 
 
Loss of CL leads to increased expression of iron uptake genes: 
In order to understand the cellular response to CL deficiency, we 
performed a genome-wide microarray analysis in cells of the CL synthase mutant 
crd1Δ, which completely lacks CL (Chang et al., 1998b; Jiang et al., 1997; Tuller 
et al., 1998). The microarray analysis revealed increased expression of genes 
involved in iron homeostasis in the crd1Δ mutant (Patil et al., 2012). To confirm 
the effect of loss of CL on expression of the iron regulon genes, we carried out 
quantitative PCR analysis of the Aft1-regulated iron uptake genes in crd1Δ. Cells 
were grown in SD respiratory media to the logarithmic growth phase and RNA 
was extracted for mRNA quantitation, as described in the “Materials and 
Methods.” As seen in Fig. 2.1, the mRNA levels of AFT1, FIT1-3, FET3, FTR1 
and ARN1-3 were upregulated more than 3-fold in crd1Δ. Up-regulation of AFT1 
and the iron regulon genes in the crd1Δ mutant suggested either deficient cellular 
iron levels or perturbation of mitochondrial Fe-S cluster biogenesis, and/or export 
of extra-mitochondrial Fe-S co-factors are perturbed in this mutant (Chen et al., 
2004; Hausmann et al., 2008; Kispal et al., 1999). 
 
Perturbation of iron homeostasis in crd1Δ: 
 We quantified mitochondrial iron using ICP-OES (inductively coupled 
plasma-optical emission spectroscopy) and found that iron levels in the crd1Δ 
mutant were significantly increased by 33% relative to WT levels (Fig. 2.2). This  
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Figure 2.1. Increased expression of the iron regulon in crd1Δ. The mRNA 
levels of iron regulon genes were quantified by qPCR from cells grown in SD 
glycerol-ethanol at 30°C to the logarithmic phase. Values are reported as fold 
change in expression over WT. Expression was normalized to the mRNA levels 
of the internal control ACT1. Data shown are mean ± SE (n=6).  
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Figure 2.2. Increased mitochondrial iron levels in crd1Δ. (This experiment 
was carried out in the laboratory of Dr. Dennis R. Winge, University of Utah 
Health Sciences Center) Cells were grown in YP-galactose at 30°C to the 
logarithmic phase, and mitochondrial iron levels were determined by ICP-OES. 
Data shown are mean ± SE (n=9). The asterisk indicates a significant difference 
relative to WT. 
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 result suggested that the iron regulon in crd1Δ is upregulated for a reason other 
than low cellular iron levels. Previous studies have reported that mutations in 
yeast genes involved in Fe-S cluster synthesis or in the export of Fe-S co-factors 
lead to elevated mitochondrial iron levels (Garland et al., 1999; Hausmann et al., 
2008; Kispal et al., 1997; Knight et al., 1998; Li et al., 1999; Muhlenhoff et al., 
2002).  
Perturbation of mitochondrial Fe-S biogenesis leads to growth sensitivity 
in the presence of FeSO4 (Foury, 1999; Foury et al., 2007; Leidgens et al., 2010; 
Ramazzotti et al., 2004). As seen in Fig. 2.3B-C, crd1Δ cells showed growth 
sensitivity to 5 mM and 10 mM FeSO4. This sensitivity to iron supplementation 
was observed when crd1Δ cells were grown in galactose (respiro-fermentative) 
and ethanol (respiratory) but not in glucose (fermentable) media (Fig. 2.3A). This 
is most likely because cells have a greater demand for iron in respiratory and 
respiro-fermentative media, in order to synthesize heme and Fe-S containing 
proteins involved in oxidative phosphorylation (Garber Morales et al., 2010; 
Kaplan et al., 2006). 
Increased mitochondrial iron levels cause hypersensitivity to oxidative 
stress (Babcock et al., 1997; Muhlenhoff et al., 2002; Schilke et al., 1999), which 
may be reflected in sensitivity to ROS inducing agents. Consistent with increased 
oxidative stress, crd1Δ cells exhibited increased sensitivity to the ROS-inducing 
agent H2O2 (Fig. 2.3D). In summary, the absence of CL leads to increased 
mitochondrial iron levels as well as sensitivity to iron supplementation and 
oxidative stress, consistent with perturbation of iron homeostasis. 
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Figure 2.3. Sensitivity of crd1Δ to iron and H2O2. Cells were precultured in 
YPD overnight, serially diluted, spotted on SD plates containing (A) glucose + 
FeSO4, (B) galactose + FeSO4, (C) ethanol + FeSO4, and (D) galactose + H2O2, 
and incubated at 30°C for 5 days. 
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Fe-S deficiencies in crd1Δ: 
We explored the possibility that the iron homeostasis defects in the crd1Δ 
mutant resulted from perturbation of Fe-S biogenesis. Perturbation of 
mitochondrial Fe-S assembly has been shown to cause decreased activity of 
mitochondrial proteins containing Fe-S clusters (Gerber et al., 2004; Lange et al., 
2000; Muhlenhoff et al., 2002). To this end, we assayed the activities of the Fe-S 
enzymes succinate dehydrogenase, ubiquinol-cytochrome c oxidoreductase, and 
aconitase in crd1Δ. As seen in Table 2.3, these enzyme activities were 
decreased by approximately 36%, 45%, and 78% respectively, in the crd1Δ 
mutant. In addition, cytochrome c oxidase activity was decreased by 30% in the 
crd1Δ mutant (data not shown), consistent with previous studies (Fry and Green, 
1980; Jiang et al., 2000; Robinson, 1993; Sedlak and Robinson, 1999). The 
decreased activities of mitochondrial Fe-S proteins in crd1Δ are not due to 
reduced transcription of SDH2, RIP1, and ACO1 (Patil et al., 2012). These 
results indicate that CL is required for the activity of mitochondrial Fe-S proteins 
present in the inner membrane and matrix. 
Mitochondrial Fe-S cluster biogenesis is also required for the maturation of 
cytosolic Fe-S proteins, as cytosolic Fe-S assembly depends on Fe-S co-factors 
synthesized in the mitochondria (Gerber et al., 2004; Kispal et al., 1999; Lange et 
al., 2000; Muhlenhoff et al., 2002). To determine the impact of CL deficiency on 
the activities of cytosolic Fe-S proteins, we measured the activities of sulfite 
reductase, which catalyzes the conversion of sulfite to sulfide, and 
isopropylmalate isomerase, which catalyzes the inter-conversion of alpha-
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isopropylmalate and beta-isopropylmalate (Hsu and Schimmel, 1984; Masselot 
and De Robichon-Szulmajster, 1975; Masselot and Surdin-Kerjan, 1977; Skala et 
al., 1991). Sulfite reductase and isopropylmalate isomerase each contain a 4Fe-
4S cluster (Balk et al., 2005; Crane et al., 1997; Yoshimoto and Sato, 1968). As 
seen in Table 2.3, sulfite reductase activity was decreased by ~46% in crd1Δ. 
Because sulfite reductase is required for the synthesis of methionine and 
cysteine, a decrease in activity would be expected to lead to methionine 
auxotrophy. As seen in Fig. 2.4A, crd1Δ was auxotrophic for methionine at 
elevated temperature. The crd1Δ mutant also exhibited a ~49% decrease in 
activity of the leucine biosynthetic pathway enzyme isopropylmalate isomerase 
(Table 2.3) along with leucine auxotrophy at elevated temperature (Fig. 2.4B). 
These results indicate that the loss of CL also affects activity of Fe-S proteins in 
the cytosol. Taken together, these experiments indicate that activities of both 
mitochondrial and cytosolic Fe-S enzymes are affected by CL deficiency. 
 
Genetic interaction between CRD1 and ISU1: 
 If CL is required for the biogenesis of Fe-S clusters in the mitochondria, 
crd1Δ would be expected to be sensitive to further perturbation of Fe-S 
biogenesis. Most of the genes involved in Fe-S cluster assembly, including 
NFS1, ISD11, YAH1, and ARH1 are required for viability (Barros and Nobrega, 
1999; Li et al., 1999; Manzella et al., 1998; Wiedemann et al., 2006). YFH1 
deletion mutants are viable in some genetic backgrounds, but exhibit severe  
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Table 2.3. Decreased mitochondrial and cytosolic Fe-S enzyme activities in 
crd1Δ. Cells were grown in galactose medium and activities of Fe-S enzymes 
were assayed as described in the ‘Materials and Methods’. Data shown are 
mean ± SD (n≥4). 
 	  
	  
a These cells were grown at 35°C. For sulfite reductase and isopropylmalate 
isomerase assays, cells were grown in media lacking methionine and cysteine, or 
leucine, respectively. 
b These cells were grown at 34°C.  
c These assays were carried out in the laboratory of Dr. Dennis R. Winge, 
University of Utah Health Sciences Center. 
  
 % activity in crd1Δ 
relative to WT 
Mitochondrial Fe-S enzymes   
   Succinate dehydrogenasec 63.4 ± 9.5% 
   Ubiquinol cytochrome c oxidoreductasec 54.2 ± 13.8% 
   Aconitasea 22.2 ± 13.89% 
Cytosolic Fe-S enzymes  
   Sulfite reductase 54.2 ± 1.81% 
   Isopropylmalate isomeraseb 51.76 ± 9.27% 
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Figure 2.4. Methionine and leucine auxotrophy in crd1Δ. (A) Cells were 
precultured overnight in galactose medium, serially diluted, spotted on SD 
galactose media plates lacking methionine and incubated for 3-5 days. (B) Cells 
were precultured overnight in galactose medium lacking leucine, serially diluted, 
spotted on SD glucose plates lacking leucine and incubated for 3-5 days. 
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growth defects (Lesuisse et al., 2003; Zhang et al., 2005b). However, ISU1 and 
ISU2 both encode the mitochondrial Fe-S scaffolding protein and have 
overlapping functions. Single mutants isu1Δ and isu2Δ do not show growth 
defects, as the presence of either Isu1 or Isu2 is sufficient for survival, but 
deletion of both genes is lethal (Gerber et al., 2004; Schilke et al., 1999). The 
crd1Δisu1Δ double mutant showed a synthetic growth defect in galactose media, 
but crd1Δisu2Δ grew normally (Fig. 2.5A). Isu1 is a more abundant scaffolding 
protein than Isu2 (Andrew et al., 2008), which likely accounts for the more severe 
phenotypic defect of the crd1Δisu1Δ mutant. To confirm that genetic defects 
observed in the crd1Δisu1Δ double mutant are due to deletion of ISU1, we re-
introduced ISU1 under the control of the TETOFF promoter on a low-copy plasmid, 
this overexpression of ISU1 in the crd1Δisu1Δ double mutant reversed the 
growth defect (Fig. 2.5B).  
The genetic interaction between crd1Δ and isu1Δ is consistent with 
perturbation of Fe-S biogenesis in crd1Δ and suggests that decreased Fe-S 
biogenesis resulting from CL deficiency is exacerbated by further loss of the Fe-S 
scaffold in the presence of the isu1Δ mutation.  
 
Increased expression of ATM1 does not rescue iron defects in crd1Δ: 
 The inner membrane protein Atm1, which is involved in the export of Fe-S 
co-factors from mitochondria, is activated by CL (Kuhnke et al., 2006): the in vitro 
activity of Atm1 is ~50% lower in the absence of CL. If upregulation of the iron 
regulon resulted from reduced Atm1 activity, then increasing Atm1 levels in  
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Figure 2.5. Genetic interaction between crd1Δ and isu1Δ. (A) Cells were 
precultured overnight in YPD, serially diluted, spotted on SD glucose or 
galactose plates, and incubated at 30°C for 3-5 days. (B) Cells were precultured 
overnight in SD glucose lacking tryptophan, serially diluted, spotted on SD 
glucose or galactose plates lacking tryptophan, and incubated for 3-5 days.  
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crd1Δ cells might be expected to restore the elevated iron regulon to WT levels. 
However, overexpression of ATM1 in crd1Δ cells did not restore the expression 
of FET3, FIT2, and FIT3 to WT levels (Fig. 2.6). In addition, others have shown 
that loss of ATM1 does not affect the activities of aconitase and succinate 
dehydrogenase (Kispal et al., 1999).  Therefore, it is not likely that Fe-S defects 
in the CL mutant result from Atm1 deficiency. 
 
Increased expression of antioxidant genes does not rescue iron defects in 
crd1Δ: 
Published studies have shown that Fe-S clusters in proteins such as 
aconitase are particularly sensitive to degradation by superoxide (Moreno-
Cermeno et al., 2010; Vasquez-Vivar et al., 2000). In a previous study, we 
showed that the loss of CL leads to decreased stability of respiratory 
supercomplexes (Pfeiffer et al., 2003), which is expected to cause increased 
ROS formation. Consistent with this, protein carbonylation, a sensitive marker of 
intracellular ROS, was significantly increased in crd1Δ (Chen et al., 2008a). 
Therefore, we addressed the possibility that the iron-associated growth defects in 
crd1Δ cells may result from increased ROS. To do so, we determined the effect 
on crd1Δ cells of increasing antioxidant production via overexpression of YAP1, 
which regulates expression of a number of antioxidant genes required for 
tolerance to oxidants (Lee et al., 1999; Wemmie et al., 1997). In response to 
H2O2, Yap1 positively regulates genes that affect glutathione metabolism (GSH1,  
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Figure 2.6. Overexpression of ATM1 in crd1Δ does not restore wild type 
expression of iron-uptake genes. The mRNA levels of FET3, FIT2, and FIT3 
were quantified by qPCR in cells grown in SD glycerol-ethanol at 30°C to the 
logarithmic phase. Values are reported as fold change in expression over WT. 
Expression was normalized to the mRNA levels of the internal control ACT1. 
Data shown are mean ± SE (n=6). 
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GLR1, ZWF1), catalase (CTT1), cytosolic thioredoxins (TRR1, TRX2), 
glutathione peroxidases (GPX1, GPX2), and superoxide dismutases (SOD1, 
SOD2) (Jamieson, 1998; Lee et al., 1999; Lucau-Danila et al., 2005; Sugiyama et 
al., 2000). As seen in Fig. 2.7, overexpression of YAP1 in crd1Δ did not alleviate 
methionine auxotrophy or growth sensitivity to iron and H2O2. Thus, there is no 
evidence that the iron-related growth phenotypes in crd1Δ arise from oxidative 
stress. 
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Figure 2.7. Overexpression of YAP1 in crd1Δ does not alleviate the iron-
related growth phenotypes. Cells were precultured in SD media overnight, 
serially diluted and spotted on SD galactose plates (A) supplemented with 
FeSO4, (B) supplemented with H2O2, and (C) lacking methionine. Plates were 
incubated for 5 days. 
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Figure 2.8.  Model: Perturbation of Fe-S biogenesis in crd1Δ. In the proposed 
model, loss of CL leads to decreased Fe-S biogenesis and maturation of Fe-S 
proteins, resulting in reduced activities of succinate dehydrogenase (II), 
ubiquinol-cytochrome c oxidoreductase (III), and aconitase (Aco1) in the 
mitochondria, as well as cytosolic Fe-S enzymes (Cyt Fe-S) sulfite reductase and 
isopropylmalate isomerase. Decreased Fe-S biogenesis is sensed by Aft1, which 
activates expression of the iron regulon genes, leading to increased 
mitochondrial iron levels. 
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DISCUSSION 
 
In this study, we show for the first time that CL deficiency leads to altered 
mitochondrial and cellular iron homeostasis, as seen in increased expression of 
the iron regulon genes, elevated mitochondrial iron levels, and sensitivity to iron 
supplementation and ROS inducing agents. Our findings indicate that the most 
likely mechanism underlying the iron homeostasis defects is that of perturbation 
of Fe-S biogenesis, as is evident from decreased activities of both mitochondrial 
and cytosolic Fe-S enzymes, concomitant auxotrophies for the amino acid 
products of these enzymes, and synthetic interaction of crd1Δ with the 
mitochondrial Fe-S scaffolding mutant isu1Δ. The observed decrease in Fe-S 
enzyme activity is not likely to result solely from a loss of direct enzyme activation 
by CL in the mitochondrial inner membrane. While the mitochondrial enzymes 
succinate dehydrogenase and ubiquinol-cytochrome c oxidoreductase are 
membrane-bound and may be activated by CL, aconitase is a matrix enzyme that 
is unlikely to be directly regulated by CL. Furthermore, we observed reduced 
activity of cytosolic Fe-S enzymes sulfite reductase and isopropylmalate 
isomerase, which are not in contact with the mitochondrial membrane.  
How does CL deficiency cause perturbation of mitochondrial Fe-S 
biogenesis? Several potential mechanisms can be ruled out. First, the Fe-S 
defects are most likely not due to decreased Atm1 activity, as overexpression of 
ATM1 did not rescue the iron regulon defects (Fig. 2.6). Furthermore, as previous 
studies indicated that aconitase and succinate dehydrogenase activities are not 
affected by decreased expression of ATM1, it is unlikely that decreased activities 
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of aconitase and succinate dehydrogenase observed in the CL mutant result 
from Atm1 deficiency (Kispal et al., 1999). A second potential mechanism, 
disruption of Fe-S clusters by increased ROS in the CL mutant, is also unlikely, 
as overexpression of YAP1 in crd1Δ did not alleviate methionine auxotrophy or 
growth sensitivity to iron and H2O2 (Fig. 2.7). Furthermore, we observed elevated 
expression of the iron regulon genes even in fermentative growth conditions, 
during which protein carbonylation in CL mutants is not increased (Chen et al., 
2008a). In addition, expression of antioxidant genes is not increased during these 
growth conditions in crd1Δ (Patil et al., 2012). Therefore, there is no evidence 
that ROS contributes to the observed iron phenotypes of crd1Δ cells. 
A third possibility, perturbation of glutathione (GSH) metabolism, is also 
not a likely cause of Fe-S defects in the CL mutant. GSH plays a critical role in 
maintaining an intracellular reducing environment and regulates cellular iron 
homeostasis (Kumar et al., 2011; Sipos et al., 2002). While perturbation of GSH 
metabolism does lead to elevated mitochondrial iron levels and decreased 
cytosolic Fe-S biogenesis, depletion of GSH does not affect activities of the 
mitochondrial Fe-S proteins succinate dehydrogenase and aconitase, which are 
reduced in crd1Δ (Sipos et al., 2002). However, depletion of GSH, a tripeptide of 
glutamate, cysteine, and glycine, is a predicted outcome of Fe-S deficiency. First, 
the glutamate precursor α-ketoglutarate is likely to be depleted as a result of 
aconitase deficiency.  Second, decreased activity of the Fe-S enzyme glutamate 
synthase would lead to a decrease in the conversion of glutamine and α-
ketoglutarate to glutamate (Shakoury-Elizeh et al., 2004; Vanoni and Curti, 
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1999). Third, decreased activity of sulfite reductase is expected to affect 
synthesis of methionine, the sulfur donor for synthesis of cysteine. Therefore, it is 
probable that glutathione deficiency is a downstream effect of Fe-S defects in 
CL-deficient cells.  
Previous studies have indicated that yeast cells exhibit iron deficiency 
resulting from defective vacuolar protein sorting or activation of Fet3, which may 
activate the iron regulon (Davis-Kaplan et al., 2004; Radisky et al., 1997). 
However, defective vacuolar function is not a likely cause of upregulation of the 
iron regulon in crd1Δ cells because, in the current study, mitochondria from 
crd1Δ cells contain elevated, rather than decreased, levels of iron. 
The most likely explanation for perturbation of Fe-S biogenesis in CL 
deficient cells is that alterations in the mitochondrial membrane perturb the 
stability and integrity of the protein complexes that drive mitochondrial protein 
import (Kutik et al., 2008; Tamura et al., 2009). We have shown that crd1Δ cells 
exhibit defective import of precursor proteins into mitochondria (Jiang et al., 
2000; Kutik et al., 2008). Cells lacking CL may be compromised in the import of a 
protein or nutrient important for Fe-S biogenesis in the matrix. Recent studies 
have shown that Zim17, a heat-shock protein, interacts with both Ssc1 and PAM 
to promote their activities (Diaz de la Loza Mdel et al., 2011; Sanjuan Szklarz et 
al., 2005). Mitochondria from the ZIM17 mutant exhibit decreased protein import 
due to aggregation of Pam16, Ssc1, and Ssq1 proteins (Burri et al., 2004; Diaz 
de la Loza Mdel et al., 2011; Sanjuan Szklarz et al., 2005; Yamamoto et al., 
2005). Aggregation of both Ssc1 and Ssq1 result in decreased Fe-S biogenesis, 
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leading to upregulation of the Aft1-controlled iron regulon. The loss of CL may 
affect mitochondrial import or processing of Fe-S biosynthetic proteins or, 
alternatively, affect nutrient import through inner membrane carrier proteins. 
Experiments to address this mechanism are in progress. 
We propose the following model for the role of CL in maintaining 
mitochondrial and cellular iron homeostasis (Fig. 2.8). CL deficiency leads to 
decreased mitochondrial import of Fe-S proteins resulting in defects in Fe-S 
cluster biogenesis and maturation of Fe-S proteins and thus reduced activities of 
mitochondrial and cytosolic Fe-S enzymes. The cellular response to the 
decrease in Fe-S biogenesis is up-regulation of the iron regulon, leading to 
elevated mitochondrial iron levels. 
It remains unclear how CL deficiency contributes to the observed 
pathology in BTHS. Interestingly, some of the clinical symptoms found in BTHS 
patients are also seen in patients with Fe-S biogenesis defects. Mutations in the 
human ISCU gene, which is homologous to yeast ISU1, lead to deficiencies in 
succinate dehydrogenase and aconitase in skeletal muscle, causing 
cardiomyopathy, lactic acidosis, muscle weakness, and exercise intolerance (Hall 
et al., 1993; Haller et al., 1991; Kollberg et al., 2009; Mochel et al., 2008). 
Depletion of several proteins of the Fe-S biosynthetic machinery severely affects 
mitochondrial inner membrane structure and cristae morphology (Biederbick et 
al., 2006; Sheftel et al., 2012), similar to what has been observed in the 
lymphoblasts of BTHS patients (Acehan et al., 2007). In addition, deficiency of 
frataxin, which is involved in mitochondrial Fe-S biogenesis, is characterized by 
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hypertrophic cardiomyopathy and heart failure (Durr et al., 1996). Interestingly, 
overexpression of frataxin leads to increased mitochondrial membrane potential, 
elevated ATP levels, resistance to oxidative stress, and life-span extension 
(Ristow et al., 2000; Runko et al., 2008), defects which are characteristic of CL 
deficiency (Joshi et al., 2009). In transgenic mice, overexpression of frataxin 
counteracted cardiotoxic stress, preventing cardiomyopathy and cardiac failure 
(Schulz et al., 2010). We suggest that mitochondrial iron homeostasis may be an 
important physiological modifier that contributes to the phenotypes observed in 
BTHS patients. 
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CHAPTER 3 
 
 
LOSS OF CARDIOLIPIN LEADS TO GLUTATHIONE DEFICIENCY 
 
INTRODUCTION 
 
In the studies discussed in the previous chapter, I demonstrated that CL 
deficiency leads to perturbation of iron homeostasis due to decreased Fe-S 
biogenesis (Patil et al., 2012). The majority of iron taken up by yeast cells is 
utilized for the synthesis of Fe-S clusters, which are incorporated as co-factors 
into iron-dependent enzymes (Kaplan et al., 2006). In addition to enzymes 
required for mitochondrial bioenergetics, several amino acid biosynthetic 
enzymes are dependent on Fe-S clusters (Lill and Muhlenhoff, 2008). In yeast, 
iron-dependent enzymes involved in amino acid synthesis include aconitase 
(Aco1), glutamate synthase (Glt1), sulfite reductase (Met5), dihydroxyacid 
dehydratase (Ilv3), isopropylmalate isomerase (Leu1), and homoaconitase (Lys4) 
(Lill and Muhlenhoff, 2008). Therefore, decreased Fe-S biogenesis is expected to 
disrupt amino acid synthesis, causing severe metabolic perturbations.  
As discussed in chapter two, I have shown that the crd1Δ mutant exhibits 
decreased activity of aconitase (Patil et al., 2012). Aconitase catalyzes the 
conversion of citrate to isocitrate, which is converted to α-ketoglutarate by 
isocitrate dehydrogenase (Cupp and McAlister-Henn, 1991; Cupp and McAlister-
Henn, 1992). α-ketoglutarate is an essential substrate for the synthesis of 
glutamate (Chen et al., 2005; Gangloff et al., 1990). A decrease in α-
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ketoglutarate is expected to cause depletion of glutamate. Sulfite reductase, 
which catalyzes the conversion of sulfite to sulfide, is essential for the synthesis 
of both methionine and cysteine (Masselot and De Robichon-Szulmajster, 1975; 
Masselot and Surdin-Kerjan, 1977). The crd1Δ mutant exhibits decreased activity 
of sulfite reductase along with auxotrophy for methionine (Patil et al., 2012). 
Depletion of these amino acids is expected to decrease the synthesis of 
glutathione (GSH), an essential antioxidant. GSH is synthesized in the cytosol 
from glutamate, cysteine, and glycine, through sequential reactions catalyzed by 
Gsh1 (γ-glutamyl cysteine synthase) and Gsh2 (glutathione synthase) (Inoue et 
al., 1998; Ohtake and Yabuuchi, 1991) (Fig. 3.1). The synthesis of GSH is under 
the regulatory control of the transcription factor Yap1 (Lee et al., 1999; Sugiyama 
et al., 2000; Wu and Moye-Rowley, 1994). Activation of Yap1 by oxidative stress 
and temperature shock, or by overexpression of the YAP1 gene augments the 
expression of GSH1 and GSH2 and elevates GSH levels (Sugiyama et al., 2000; 
Wu and Moye-Rowley, 1994).  
GSH is the major free thiol that functions to maintain a reducing 
environment and to combat oxidative stress (Kumar et al., 2011; Meister, 1988; 
Penninckx, 2002). GSH acts as a co-factor for antioxidant enzymes such as 
glutathione peroxidase, which utilize GSH to neutralize the reactive oxygen 
species (ROS) (Jamieson, 1998). The antioxidant function of GSH depends on 
the active thiol group (-SH) (Jamieson, 1998). GSH donates electrons necessary 
to reduce the ROS, and in turn, is oxidized to glutathione disulfide (GSSG). To 
regenerate GSH, glutathione reductase (Glr1) catalyzes the reduction of GSSG,  
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Figure 3.1. The GSH biosynthetic pathway and the redox cycle in yeast. 
Enzymes are indicated in red, and intermediate steps are shown in blue. 
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and NADPH for this reaction is provided by glucose 6-phosphate dehydrogenase 
(Zwf1) (Grant, 2001; Izawa et al., 1998; Nogae and Johnston, 1990; Outten and 
Culotta, 2004; Outten et al., 2005) (Fig. 3.1). The depletion of GSH leads to 
increased sensitivity to oxidants such as hydrogen peroxide (H2O2), while 
elimination of GSH synthesis by the deletion of GSH1 leads to growth arrest 
(Jamieson, 1998). Therefore, to maintain vital cellular functions, intracellular GSH 
levels must be rigorously maintained by de novo synthesis, redox cycling, or 
uptake from the growth media. 
Because activities of Fe-S enzymes involved in the synthesis of glutamate 
and cysteine are decreased, I hypothesized that growth defects observed in 
crd1Δ cells are due to depletion of glutamate and cysteine, which leads to GSH 
deficiency. Consistent with this prediction, growth of crd1Δ at elevated 
temperature is restored by supplementation of both glutamate and cysteine or 
GSH. The data presented in this study show for the first time that CL is required 
for the synthesis of GSH. 
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MATERIALS AND METHODS 
 
Yeast strains and growth media 
 The yeast strains used in this study are listed in Table 1. Synthetic defined 
(SD) medium contained adenine (20.25 mg/l), arginine (20 mg/l), histidine (20 
mg/l), leucine (60 mg/l), lysine (20 mg/l), methionine (20 mg/l), threonine (300 
mg/l), tryptophan (20 mg/l), and uracil (20 mg/l), yeast nitrogen base without 
amino acids (Difco, Detroit, MI), and carbon source (fermentative) glucose (2%) 
or (respiratory) glycerol (3%) plus ethanol (1%) or (respiro-fermentative) 
galactose (2%). SD drop out medium contained all of the above-mentioned 
ingredients except for the indicated amino acid. For testing iron sensitivity, the 
growth media was supplemented with 1 µM CuSO4 and FeSO4 was solubilized in 
0.1 N HCl, filter-sterilized and added to the culture medium at the indicated 
concentration. GSH stock (250 mM) was prepared in distilled water, filter-
sterilized and diluted to achieve the desired final concentration. 
 
Construction of double mutants 
 The CL mutant strain crd1Δ::URA3 MATα was crossed with mutants of the 
opposite mating type obtained from the yeast deletion collection (Invitrogen). 
Heterozygous diploids were selected on SD dropout media lacking methionine 
and lysine, sporulated, and tetrads were dissected. Synthetic interactions 
between CL and deletion mutants was determined by comparing growth of the 
double mutant to isogenic parent and wild type strains on YPD. 
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Table 3.1. Yeast strains and plasmids used in this study.  
 
 
  
Strain Genotype Reference 
FGY3 MATa, ura3-52, lys2-801, ade2-101, trp1-Δ1, his3-Δ200, leu2-Δ1 (Jiang et al., 1997) 
FGY2 MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1, his3-Δ200, leu2-Δ1, crd1Δ::URA3 (Jiang et al., 1997) 
BY4742 MATα, his 301, leu 200, lys 200, ura 300 Invitrogen BY4742 MATα, his 301, leu 200, lys 200, ura 300 Invitrogen 
VGY1 MATα, his 301, leu 200, lys 200, ura 300, crd1Δ::URA3 (Gohil et al., 2005) 
gsh1Δ MATa, his 301, leu 200, met 1500, ura 300, gsh1Δ::KanMX4 Invitrogen 
glr1Δ MATa, his 301, leu 200, met 1500, ura 300, glr1Δ::KanMX4 Invitrogen 
zwf1Δ MATa, his 301, leu 200, met 1500, ura 300, zwf1Δ::KanMX4 Invitrogen 
VGY1 
gsh1Δ 
MATa, his 301, leu 200, met 1500, ura 300, 
gsh1Δ::KanMX4, crd1Δ::URA3 This study 
VGY1 
glr1Δ 
MATa, his 301, leu 200, met 1500, ura 300, 
glr1Δ::KanMX4, crd1Δ::URA3 This study 
VGY1 
zwf1Δ 
MATα, his 301, leu 200, lys 200, ura 300, 
zwf1Δ::KanMX4, crd1Δ::URA3 This study 
YEp351 High-copy number plasmid, LEU2 nutritional marker (Hill et al., 1986) 
YEp351-
YAP1 
Derivative of YEp351, expresses YAP1 from the 
native promoter 
(Wemmie et al., 
1994) 
 67 
 
Mitochondria isolation 
Mitochondria were isolated from cell lysates prepared as previously 
described (Diekert et al., 2001). Briefly, spheroplasts obtained by zymolase 
treatment were disrupted by Dounce homogenization, and mitochondria were 
isolated by differential centrifugation. Total protein concentration was determined 
with a Bradford assay kit (BioRad), with BSA as the standard. 
 
SDS-PAGE and western blot analyses of mitochondrial Fe-S assembly 
proteins 
 Mitochondria isolated from cells grown to an A550 of 1.0 were lysed in 
sample buffer (250 mM Tris pH 6.8, 2% SDS, 10% glycerol, 0.01% bromophenol 
blue, and 20% β-mercaptoethanol) by heating the lysate to 95°C for 5 mins. The 
lysate was subjected to SDS-PAGE and transferred to polyvinylidene difluoride 
membrane as described in Zhong et al. (2007). The blots were probed with 
polyclonal primary antibodies (rabbit) against Yfh1 and Nfs1 (gifts from Dr. 
Andrew Dancis), and Isu and porin (gifts from Dr. Roland Lill). Anti-rabbit IgG 
horseradish peroxidase-conjugated secondary antibodies (Promega) were 
visualized with ECL Prime chemiluminescence detecting reagents.  
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RESULTS 
 
Growth of crd1Δ at elevated temperature is restored by supplementation 
with GSH or with glutamate and cysteine: 
The data presented in the previous chapter showed that the loss of CL 
leads to decreased activities of Fe-S enzymes aconitase and sulfite reductase 
(Patil et al., 2012). Because these enzymes are essential for the synthesis of 
glutamate and the sulfur-containing amino acids (methionine or cysteine), 
respectively, I hypothesized that the growth defect in crd1Δ at elevated 
temperature may be due to depletion of both glutamate and cysteine. Consistent 
with this prediction, the growth of crd1Δ at elevated temperature is restored by 
supplementation of glutamate and cysteine (Fig. 3.2). Supplementation of 
cysteine alone partially rescued the growth defect in crd1Δ, but glutamate alone 
did not (Fig. 3.3). This suggests that cysteine, and to a lesser extent, glutamate 
levels are decreased in the crd1Δ mutant. 
Both glutamate and cysteine are essential precursors for the synthesis of 
GSH. Because crd1Δ cells are auxotrophic for glutamate and cysteine, I further 
predicted that the growth defect in crd1Δ at elevated temperature is due to GSH 
deficiency. Consistent with this prediction, the growth defect of crd1Δ was 
rescued by GSH supplementation (Fig. 3.4). These results indicate that GSH 
deficiency in the CL mutant is due to the depletion of both glutamate and 
cysteine. 
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Figure 3.2. Supplementation of glutamate and cysteine restored the growth 
of crd1Δ at elevated temperature. Cells were precultured in SD galactose 
overnight, serially diluted, and spotted on SD galactose plates containing the 
indicated amounts of glutamate and cysteine, and incubated at 37°C for 4 days. 
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Figure 3.3. Supplementation of cysteine partially rescued the growth of 
crd1Δ at elevated temperature. Cells were precultured in SD galactose 
overnight, serially diluted, and spotted on SD galactose plates containing the 
indicated amounts of (A) glutamate or (B) cysteine, and incubated at 37°C for 4 
days.  
B 
A 
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Figure 3.4. GSH supplementation restored the growth of crd1Δ at elevated 
temperature. Cells were precultured in SD galactose overnight, serially diluted, 
spotted on SD galactose plates containing the indicated amounts of GSH, and 
incubated at 37°C for 4 days.  
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Overexpression of YAP1 did not rescue growth of crd1Δ at elevated 
temperature: 
GSH is synthesized from glutamate, cysteine, and glycine, through 
sequential reactions catalyzed by Gsh1 and Gsh2 (Inoue et al., 1998; Ohtake 
and Yabuuchi, 1991). Expression of both GSH1 and GSH2 is regulated by the 
transcription factor Yap1 (Sugiyama et al., 2000). Consistent with this, 
overexpression of YAP1 activates the transcription of GSH1 and GSH2, thereby 
increasing GSH levels (Sugiyama et al., 2000). To address the possibility that 
GSH deficiency results from decreased GSH biosynthetic enzymes, YAP1 was 
overexpressed in crd1Δ cells. In contrast to GSH supplementation, 
overexpression of YAP1 did not rescue the growth of crd1Δ at elevated 
temperature (Fig. 3.5). This suggests that GSH deficiency in crd1Δ does not 
result from deficient enzymes for the synthesis of GSH. 
 
GSH supplementation alleviates growth sensitivity of crd1Δ to oxidants: 
Previous studies have shown that the loss of CL leads to increased 
oxidative stress, and that the crd1Δ mutant is sensitive to growth in the presence 
of iron and H2O2 (Chen et al., 2008a; Patil et al., 2012). In yeast cells, GSH is the 
most abundant antioxidant molecule that is essential to maintain resistance to 
oxidants (Jamieson, 1998). Consistent with this, GSH deficient mutants are 
hypersensitive to H2O2 (Jamieson, 1998). To address the possibility that GSH 
deficiency in crd1Δ may account for growth sensitivity of the mutant to iron and 
H2O2, crd1Δ cells were grown in the presence of 7 mM FeSO4 or 350 mM H2O2, 
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Figure 3.5. Overexpression of YAP1 did not alleviate the growth defect of 
crd1Δ at elevated temperature. Cells were precultured in SD galactose 
overnight, serially diluted, spotted on SD galactose plates lacking leucine, and 
incubated for 4-5 days. 
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in the presence or absence of 1 mM GSH. GSH supplementation significantly 
improved the growth of crd1Δ in the presence of iron or H2O2 (Fig. 3.6). This 
suggests that the growth sensitivity of crd1Δ to oxidants is due to GSH 
deficiency. 
 
Genetic interaction between CRD1 and GSH metabolic pathway genes: 
If the loss of CL leads to GSH deficiency, which accounts for the 
increased ROS, then further perturbation of GSH synthesis could be expected to 
exacerbate the growth defect of crd1Δ. Consistent with this prediction, deletion of 
GSH1 in crd1Δ cells leads to synthetic lethality (Fig. 3.7). The genetic interaction 
between CRD1 and GSH1 is consistent with increased oxidative stress in crd1Δ, 
which is further exacerbated by the deletion of GSH1. 
To preserve a reducing environment, GSH must be maintained in the 
reduced form, by converting GSSG to GSH. For redox cycling of GSSG to GSH, 
both glutathione reductase (Glr1) and glucose 6-phosphate dehydrogenase 
(Zwf1), which provides NADPH for the reaction are required (Grant, 2001; Izawa 
et al., 1998; Nogae and Johnston, 1990; Outten and Culotta, 2004; Outten et al., 
2005). Deletion of either GLR1 or ZWF1 is expected to disrupt regeneration of 
GSH and exacerbate the growth of crd1Δ. Consistent with this prediction, 
deletion of GLR1 or ZWF1 in crd1Δ cells leads to synthetic sick interactions in 
galactose-containing media at 39°C. (Fig. 3.8). The synthetic interaction of crd1Δ 
with zwf1Δ is stronger than with glr1Δ, which suggests that, in addition to 
alterations in GSH, cytosolic NADPH levels may be decreased in crd1Δ. The 
 75 
 
 
 
 
 
 
Figure 3.6. GSH supplementation alleviated growth sensitivity of crd1Δ to 
H2O2 and FeSO4. Cells were precultured in YPD overnight, serially diluted, and 
spotted on SD galactose plates containing (A) 0.35 mM H2O2 or (B) 7 mM 
FeSO4, supplemented with 1 mM GSH as indicated, and incubated at 30°C for 5 
days. 
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Figure 3.7. Genetic interaction between crd1Δ and gsh1Δ. Cells were 
precultured in YPD overnight, serially diluted, spotted on YPD and SD glucose, 
and incubated at 30°C. 
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Figure 3.8. Genetic interaction between crd1Δ, zwf1Δ, and glr1Δ. Cells were 
precultured in YPD overnight, serially diluted, spotted on SD galactose plates, 
and incubated at 30°C and 39°C. 
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synthetic genetic interactions of gsh1Δ, zwf1Δ, and glr1Δ with crd1Δ indicate that 
perturbation of GSH metabolism in the CL mutant further contributes to the 
oxidative stress, which exacerbates the growth defect. 
 
Loss of CL leads to decreased Yfh1 levels: 
The most likely explanation for GSH deficiency in crd1Δ cells is decreased 
maturation of Fe-S proteins aconitase and sulfite reductase, which are essential 
for the synthesis of glutamate and cysteine (Gerber et al., 2004; Kispal et al., 
1999; Lange et al., 2000; Muhlenhoff et al., 2002). To test the possibility that the 
protein(s) required for mitochondrial Fe-S cluster assembly are decreased in 
crd1Δ, I carried out a Western blot analysis of the steady-state levels of three 
core components involved in mitochondrial Fe-S assembly, Yfh1, Nfs1, and Isu. 
As seen in Fig. 3.9, Yfh1, the putative iron donor for mitochondrial Fe-S 
assembly, is decreased in crd1Δ. However, Nfs1 and Isu levels are unaltered in 
the mutant. This suggests that the expression, import or stability of Yfh1 is 
decreased in crd1Δ, which may account for defective mitochondrial Fe-S 
biogenesis and GSH deficiency. 
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Figure 3.9. Decreased Yfh1 in crd1Δ. Western blot analysis of Nfs1, Yfh1, and 
Isu proteins from mitochondrial extracts of cells grown in SD galactose at 35°C. 
Por1 was used as a loading-control. 
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Figure 3.10. Proposed model for GSH deficiency in crd1Δ. Loss of CL leads 
decreased Yfh1 protein, causing perturbation of mitochondrial Fe-S biogenesis. 
Defective Fe-S biogenesis leads to elevated mitochondrial iron levels and 
decreased maturation of aconitase (Aco1) and sulfite reductase (SiR), which 
results in reduced synthesis of glutamate and cysteine, precursors required for 
GSH synthesis. Decreased GSH levels and elevated mitochondrial iron 
contribute to an increase in ROS, which inhibits the growth of crd1Δ. 
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DISCUSSION 
 
In this study, we provide evidence that perturbation of CL synthesis leads 
to GSH deficiency: 1) growth of crd1Δ at elevated temperature is restored by 
supplementation of GSH and GSH precursors; 2) GSH supplementation restored 
the growth of crd1Δ in the presence of oxidants; 3) deletion of genes for GSH 
synthesis are synthetically lethal with crd1Δ; and 4) Yfh1 levels are decreased, 
suggesting that mitochondrial Fe-S cluster assembly is reduced in crd1Δ. 
Collectively, these findings indicate that GSH deficiency in crd1Δ is due to the 
depletion of precursors for GSH synthesis, which is caused by defective Fe-S 
biogenesis. 
The finding that GSH supplementation alleviated the growth defect of 
crd1Δ at elevated temperature suggests that GSH levels in crd1Δ are decreased. 
To maintain high intracellular GSH concentrations, yeast cells can take up GSH 
from the growth media or synthesize it through the de novo pathway. In synthetic 
dropout media, which is devoid of specific amino acids and GSH, yeast cells 
depend entirely on intracellular GSH synthesis from glutamate, cysteine, and 
glycine. Auxotrophies for glutamate and cysteine suggest that synthesis of both 
amino acids are decreased in crd1Δ (Fig. 3.2), which is further supported by the 
finding that overexpression of YAP1 did not restore the growth of crd1Δ at 
elevated temperature (Fig. 3.5) or improve resistance of crd1Δ to iron and H2O2 
(Patil et al., 2012). 
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GSH supplementation restored the growth of crd1Δ in presence of both 
iron and H2O2 (Fig. 3.6), which suggests that, compared to WT cells, the CL 
mutant is unable to increase GSH synthesis to efficiently neutralize the ROS. 
This is supported by findings that mutations in genes for GSH synthesis and 
redox cycling lead to synthetic interactions with crd1Δ, which indicates that 
oxidative stress in the crd1Δ mutant is further exacerbated by perturbations in 
GSH synthesis (Figs. 3.7 and 3.8).  
A decrease in Yfh1 protein in crd1Δ suggests that the transport of iron to 
the Isu scaffold may be defective, which is consistent with decreased activity of 
Fe-S enzymes and perturbation of mitochondrial Fe-S biogenesis (Patil et al., 
2012). Several possibilities may account for decreased Yfh1 protein in crd1Δ. 
Previous studies have shown that perturbation of CL synthesis leads to 
decreased mitochondrial protein import (Gebert et al., 2009; Jiang et al., 2000). 
Consistent with this, the import of Yfh1 in CL-deficient mitochondria may be 
decreased. Alternatively, the stability of the protein may be decreased, leading to 
increased protein turnover. Yfh1 is localized in close proximity to the CL-enriched 
mitochondrial inner membrane (Campuzano et al., 1997). Interaction of Yfh1 with 
CL and/or inner membrane protein subunits of succinate dehydrogenase may be 
required for Yfh1 function (Gonzalez-Cabo et al., 2005). 
Based on the data obtained, I propose the following model to depict the 
role of CL in regulating GSH homeostasis (Fig. 3.10). Perturbation of CL 
synthesis leads to decreased Yfh1 protein, which disrupts mitochondrial Fe-S 
biogenesis. Defective Fe-S biogenesis leads to elevated mitochondrial iron levels 
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and decreased maturation of aconitase and sulfite reductase, which results in 
reduced synthesis of glutamate and cysteine, precursors required for GSH 
synthesis. Decreased GSH synthesis and elevated mitochondrial iron contribute 
to the ROS generated, which inhibits the growth of crd1Δ. 
The data presented here suggest that CL is a critical regulator of amino 
acid synthesis and GSH homeostasis. These findings could be potentially used 
to develop treatments for Barth syndrome (BTHS) patients, as early reports 
indicate that BTHS patients exhibit metabolic deficiencies similar to those 
identified in CL-deficient yeast cells (Dr. Richard Kelley, Kennedy Krieger 
Institute, John Hopkins). Mass spectrometric analyses of the plasma from BTHS 
patients indicate that the TCA cycle intermediate cis-aconitate is elevated. Cis-
aconitate is an intermediate formed during the conversion of citrate to isocitrate 
(Krebs and Holzach, 1952). Elevated cis-aconitate levels suggest that the 
enzymatic activity of aconitase may be decreased. BTHS patients also exhibit 
significant health improvement when orally supplemented with methionine, 
cysteine, or GSH (personal communication, Dr. Richard Kelley), which would be 
consistent with depletion of sulfur-amino acids in BTHS patients. In summary, the 
findings reported in this study and the preliminary data obtained from the studies 
of BTHS patients indicate that GSH could be an important physiological modifier 
of CL deficiency in BTHS. 
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CHAPTER 4 
 
SUPPRESSORS OF CRD1Δ GROWTH DEFICIENCY AT ELEVATED 
TEMPERATURE 
 
INTRODUCTION 
 
 
The primary hurdle for the effective treatment of BTHS is that the 
mechanisms linking the pathology and CL deficiency are not known. In addition, 
the clinical phenotypes of BTHS vary widely, even among patients with the 
identical mutation, suggesting that genetic and physiological factors exacerbate 
the consequences of perturbation of CL synthesis. Therefore, there is an 
imminent need to determine cellular functions of CL. 
To obtain an understanding of CL functions that might explain the cellular 
defects in BTHS, a screen was carried out to identify genes that, when 
overexpressed, compensate for the loss of CL. A previous screen for 
suppressors of growth defects of the pgs1Δ mutant led to the identification of an 
unexpected role of PG and/or CL in regulating cell wall biogenesis (Zhong and 
Greenberg, 2005). A loss-of-function mutation in the gene KRE5 restored the 
growth of pgs1Δ by strengthening the cell wall, demonstrating that PG and/or CL 
mediate cross-talk between the mitochondria and the cell wall. The current study 
was carried out to identify suppressors of crd1Δ. The crd1Δ mutant is unable to 
form colonies at elevated temperature from single cells on media containing the 
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fermentable carbon source, glucose (Jiang et al., 1999; Jiang et al., 2000; Zhong 
et al., 2004). Interestingly, studies described in chapters two and three indicate 
that CL-deficient cells exhibit perturbation of mitochondrial Fe-S biogenesis, iron 
homeostasis, GSH deficiency and growth sensitivity to iron and H2O2 in 
galactose-containing media. Although galactose, like glucose, is a fermentable 
carbon source, ATP synthesis by fermentation alone is not sufficient in 
galactose-containing media. First, galactose has to be converted to glucose 6-
phosphate by the Leloir pathway enzymes, which comprise ~5% of total cellular 
proteins (Bhat, 2008). Second, 2 ATP/galactose molecule consumed is 
inadequate to synthesize galactolytic enzymes and support growth at the same 
time. Therefore, pyruvate generated by fermentation is simultaneously oxidized 
via the TCA cycle and respiration. In contrast, in glucose-containing media, yeast 
cells almost entirely use fermentation to generate ATP, and switch to the 
respiratory mode after glucose is converted to ethanol (Lagunas, 1986). The 
difference in utilization of these two carbon sources is evident from the doubling 
time of rho° cells (cells lacking mitochondrial DNA), which is ~70 minutes in 
glucose and ~140 minutes in galactose (Bhat, 2008). Therefore, to increase 
stringency of the screen, I identified suppressors of the growth defect on 
galactose. 
The suppressor screen utilizing a high copy genomic DNA library led to 
the identification of fifty putative suppressors of crd1Δ. Five plasmids were intially 
sequenced, and interestingly, each plasmid contained the same region of 
chromosome III, spaning four genes. One of the genes was LEU2, which is 
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involved in leucine biosynthesis, a process that is perturbed in the crd1Δ mutant 
(chapter two). This supports the finding that perturbation of leucine synthesis 
likely contributes to the growth defect of crd1Δ. 
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MATERIALS AND METHODS 
 
 
Strains and growth media 
The yeast strains used in this work are listed in Table 1. The ingredients of 
synthetic defined (SD) growth media are as described in the previous chapter. 
SD glucose and SD galactose contain synthetic defined growth media lacking 
leucine, and either glucose (2%) or galactose (2%).  
Escherichia coli (E. coli) cells were grown in Luria Bertani (LB) media, 
which is composed of Bacto-tryptone (10 gm/l), yeast extract (5 gm/l), and NaCl 
(10 gm/l). E. coli transformants were selected in LB media containing ampicillin 
(100 µg/ml). 
 
Transformation and isolation of plasmids 
Transformation of plasmids in E. coli and yeast were done by 
electroporation (Delorme, 1989; Woodall, 2003). Plasmids from E. coli were 
isolated using Wizard® Plus SV Minipreps (Promega), whereas plasmids from 
yeast cells were extracted using the Zymoprep™ Yeast Plasmid Miniprep II kit 
(Zymo Research). 
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Table 4.1. Yeast and E. coli strains, and plasmids used in this study. 
 
 
 
 
 
Table 4.2. Primers used for sequencing. 
 
 
Gene Primer Sequence 
M13 F24 Forward CGCCAGGGTTTTCCCAGTCACGAC 
M13 R22 Reverse TCACACAGGAAACAGCTATGAC 
 
 
 
  
Strain Genotype Source or reference 
FGY3 MATa, ura3-52, lys2-801, ade2-101, trp1-Δ1, his3-Δ200, leu2-Δ1 
(Jiang et al., 
1997) 
FGY2 MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1, his3-Δ200, leu2-Δ1, crd1Δ::URA3 
(Jiang et al., 
1997) 
YEp351 High-copy number plasmid, LEU2 nutritional marker (Hill et al., 1986) 
YEp351-genomic 
DNA library 
Derivative of YEp351, 7-10 kb fragments of 
yeast genomic DNA, expression driven by the 
native promoter 
(Wemmie et al., 
1994)  
DH5α 
fhuA2, lacUΔ169, phoA, glnV44, Φ80' 
lacZΔM15, gyrA96, recA1, relA1, endA1, thi-1, 
hsdR17 
(Taylor et al., 
1993) 
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RESULTS 
 
 
Transformation of the cDNA library and suppressor screening: 
The crd1Δ mutant exhibits growth deficiency in galactose-containing 
media, but not in glucose, at elevated temperature (37° - 38°C) (Fig. 4.1). To 
identify genes that alleviate the growth deficiency of crd1Δ at elevated 
temperature, crd1Δ cells were transformed with a yeast genomic DNA library 
(Delorme, 1989). This library consists of 7-10 kb partially digested genomic DNA 
fragments inserted into SalI digested YEp351 (5.644 kb) plasmid. Transformants 
were selected on SD glucose Leu- plates and replicated on SD galactose Leu- 
plates. Plates were incubated at 30° and 38°C for 3-4 days. The colonies that 
grew at 38°C compared to colonies transformed with empty vector were selected. 
To eliminate false-positives, suppressors were streaked on fresh SD galactose 
Leu- plates and incubated at 38°C for 3 days (Fig. 4.2). The colonies that grew at 
38°C were re-streaked on fresh SD galactose Leu- plates and incubated at 38°C 
for the final selection (Fig. 4.3). The growth of suppressors at each step was 
compared with the growth of crd1Δ cells containing the empty plasmid (negative 
control) and WT cells containing the empty plasmid (positive control). In this 
manner, 15,000 transformants were screened and 50 putative suppressors of 
crd1Δ growth deficiency were obtained. 
 
Identification of suppressors of crd1Δ growth deficiency: 
To isolate the plasmids, the suppressors were streaked on fresh SD 
glucose Leu- plates, and cells from a single colony were inoculated into SD 
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Figure 4.1. Growth deficiency of crd1Δ in galactose at elevated 
temperature. Cells were precultured in YPD overnight, serially diluted, spotted 
on SD plates containing glucose or galactose, and incubated at 30°C or 37°C. 
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Figure 4.2. Suppressors of crd1Δ growth deficiency. Suppressors were re-
streaked on SD galactose plates lacking leucine and incubated at 38°C for 3 
days. Arrows indicate WT and crd1Δ cells containing the empty plasmid, while 
suppressors are circled. 
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Figure 4.3. Confirmation of suppressors of crd1Δ growth deficiency. To 
eliminate false-positives, suppressors (shown in Fig. 4.2) were re-streaked on 
fresh SD galactose plates lacking leucine and incubated at 38°C for 3 days. 
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glucose Leu- liquid media and incubated overnight. Because the plasmid yield 
from yeast was too low for sequencing analysis, plasmids from yeast were 
transformed into E. coli cells, and transformants were selected on LB plates 
containing ampicillin. As a pilot experiment, five plasmids were submitted to the 
AGTC sequencing facility (WSU Medical School) along with the sequencing 
primers that were specifically designed to amplify the inserted genomic DNA 
fragment (Table 2).  
 The obtained sequence information was submitted to the Saccharomyces 
Genome Database (SGD) BLAST (Basic Local Alignment Search Tool) (Fig. 4.4). 
Unfortunately, the sequence information obtained from the forward primer (M13 
F24) did not match any region in the yeast genomic DNA. Therefore, Table 3 
sequence data are based only on the M13 region amplified by the reverse primer 
(M13 R22). Interestingly, each of the five plasmids contain the same region of 
chromosome III, which comprise the suppressor genes listed in Table 3.  
 A surprising finding is that LEU2 may be a suppressor. The genetic 
background of the crd1Δ strain in the current study includes the leu2-Δ1 
mutation; thus, the LEU2 gene on the plasmid was used as the selectable marker 
for growth at 30°C. However, the plasmid alone did not rescue the growth of the 
mutant at elevated temperature. Therefore, overexpression of LEU2 may 
compensate for the decrease in leucine biosynthesis that characterizes the crd1Δ 
mutant, as shown in chapter two. 
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Figure 4.4. Genomic DNA region identified by the reverse sequencing 
primers. The dotted vertical lines show the region amplified by the sequencing 
primer, while the green arrow shows the direction of amplification. The genes 
present on the ‘Watson’ strand are indicated in red, while the genes present on 
the ‘Crick’ strand are indicated in blue. 
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Table 4.3. Putative suppressor genes of crd1Δ growth deficiency. 
 
 
 
 
* Source: Saccharomyces Genome Database (www.yeastgenome.org)  
Gene Strand Location on Chromosome III Gene function* 
LEU2 Watson 91324 è 92418 
β-isopropylmalate dehydrogenase, 
catalyzes the third step of the 
leucine biosynthetic pathway 
YCL019W Watson 85102 è 90415 Retrotransposon TYA Gag and TYB Pol genes 
YCL020W Watson 85102 è 86418 Retrotransposon TYA Gag gene co-transcribed with TYB Pol. 
YCL021W-A Watson 83620 è 83997 Putative protein of unknown function 
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DISCUSSION 
 
This study was carried out to identify genes that suppress the growth 
defect of crd1Δ in galactose-containing media at elevated temperature. In the five 
sequenced suppressors, sequences containing LEU2 restored growth of crd1Δ at 
elevated temperature. 
LEU2 encodes the enzyme β-isopropylmalate dehydrogenase, which 
catalyzes the third step of leucine biosynthesis (Andreadis et al., 1984; Kohlhaw, 
1988). The data suggest that overexpression of LEU2 rescues the growth defect 
of crd1Δ, although the control plasmid, which contains the LEU2 gene as a 
marker, does not. There may be several possible explanations for this finding. 
Overexpression of LEU2 may cause a two-fold increase in leucine over the 
control plasmid, which contains one copy of LEU2. To confirm this finding, LEU2 
should be overexpressed in a plasmid containing a different nutritional marker. 
Alternatively, other genes adjacent to LEU2 may suppress the growth defect in 
crd1Δ (Table 3). These genes are YCL021W-A, an uncharacterized open reading 
frame (ORF), and YCL019W and YCL020W, which encode the retrotransposon 
TYA Gag and TYB Pol genes, respectively. TYA Gag and TYB Pol genes are 
transcribed and translated as one polyprotein, which is processed to generate 
nucleocapsid-like protein (Gag), reverse transcriptase (RT), protease (PR), and 
integrase (IN), analogous to retroviral genes. This process may increase chances 
of insertion of Ty elements (transposon-yeast) into the genome disrupting a 
gene, which encodes a protein that is deleterious to crd1Δ. 
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Interestingly, LEU2 was isolated as a suppressor that restored the growth 
of YFH1 point mutants (yfh1-) in respiratory conditions (Bedekovics et al., 2011). 
The data in this study showed that disruption of leucine synthesis by deletion of 
LEU1 or LEU2 downregulated the transcription of ACO1, which exacerbated the 
phenotype of the yfh1- strain in respiratory conditions. The strains used in the 
studies described in chapters two and three are leu2Δ. Therefore, an alternative 
explanation for LEU2 as a suppressor of crd1Δ could be that leu2Δ may 
exacerbate the phenotype of crd1Δ at elevated temperature, whereas 
overexpression of LEU2 may restore the growth of crd1Δ by increasing ACO1 
transcription. 
Finally, leucine may be catabolized to replenish acetyl-CoA levels (Gibson 
et al., 1993; Vorapreeda et al., 2012). Recent findings in the lab suggest that 
generation of acetyl Co-A through the β-oxidation pathway in the peroxisomes 
may be defective in crd1Δ. Therefore, the growth deficiency of crd1Δ at elevated 
temperature may be due to the depletion of acetyl-CoA. A two-fold increase in 
leucine by overexpressing two-copies of LEU2 may augment acetyl-CoA levels in 
crd1Δ, thereby restoring growth at elevated temperature. In addition to these 
possibilities, sequencing the remaining suppressors may potentially provide 
insight into other cellular functions that are defective in crd1Δ. 
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CHAPTER 5 
 
FUTURE DIRECTIONS 
 
 
The data presented in chapters two and three indicate that the loss of CL 
leads to perturbation of mitochondrial Fe-S cluster biogenesis, which most likely 
causes GSH deficiency in the CL mutant. However, the underlying mechanism 
for defective Fe-S cluster biogenesis and GSH deficiency in crd1Δ cells is not 
understood. In the process of Fe-S biogenesis in mitochondria, iron (Fe) and 
sulfide (S) atoms are covalently linked to form Fe-S clusters, which are 
transferred onto recipient proteins. Key details of this process are shown in Fig. 
5.1. An exciting question for future studies is how CL plays a role in this process. 
 
1. What is the role of CL in mitochondrial Fe-S cluster biogenesis? 
The data presented in chapter two show that the loss of CL leads to 
defective mitochondrial Fe-S cluster biogenesis, which results in perturbation of 
mitochondrial and cytosolic iron homeostasis. As an indication of defective Fe-S 
cluster biogenesis, the activities of mitochondrial and cytosolic Fe-S enzymes are 
decreased in crd1Δ (Table 2.3). However, it is unclear how CL in the inner 
membrane is involved in mitochondrial Fe-S cluster biogenesis, which is largely 
carried out in the matrix. Most importantly, which step(s) of Fe-S cluster 
synthesis are perturbed in the absence of CL? Is the assembly of Fe-S clusters 
on the Isu-scaffold or the transfer of Fe-S clusters from the Isu-scaffold to 
apoproteins decreased in crd1Δ? Perturbation of either of the two steps in crd1Δ 
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Fig. 5.1. Mitochondrial Fe-S cluster biogenesis in yeast. Step 1: The 
assembly of Fe-S clusters in mitochondria begins on the Isu1 scaffold. Cysteine 
desulfurase complex (Nfs1-Isd11) catalyzes the removal of sulfur (S) from 
cysteine for delivery to Isu1. Iron (Fe) is delivered by the putative iron chaperone 
protein, frataxin (Yfh1). The source of electrons for the Fe-S assembly is most 
likely NADH, which is transferred by ferredoxin reductase (Arh1) and ferredoxin 
(Yah1). Step 2: The 2Fe-2S clusters assembled on Isu1 are transferred to the 
recipient apoproteins by interaction between Isu1 and Hsp70 chaperone Ssq1, a 
process that is assisted by Jac1, Mge1, and Grx5 proteins.  
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may suggest a direct role of CL in Fe-S cluster biogenesis. 
 
2. Why are Yfh1 levels decreased in crd1Δ? 
The experiment depicted in Fig. 3.9 indicates that steady-state levels of 
Yfh1 are decreased in crd1Δ, although Nfs1 and Isu proteins are not altered. 
What is the cause of decreased Yfh1 in crd1Δ? At least three possibilities may 
explain this decrease. First, CL is required for optimal protein import, as CL 
deficient cells exhibit decreased import of precursor proteins into mitochondria 
(Jiang et al., 2000; Kutik et al., 2008). Therefore, mitochondrial import of Yfh1 
may be decreased in crd1Δ. Protein import assays would address this possibility. 
Alternatively, the mRNA levels of YFH1 in crd1Δ may be decreased. Finally, the 
stability of Yfh1 in CL-deficient mitochondria should be examined. Any of these 
mechanisms may explain decreased Yfh1 in crd1Δ cells. 
 
3. CL and glutathione deficiency: 
The data presented in chapter three show that the growth defect of crd1Δ 
at elevated temperature and in the presence of oxidants (iron and hydrogen 
peroxide) is rescued by GSH supplementation. This suggests that crd1Δ cells are 
deficient in GSH. I suggest the following experiments to gain insight into the 
mechanism of GSH deficiency in crd1Δ cells: 
I. Amino acid deficiencies in crd1Δ. The data presented in chapter 
two suggest that glutamate and cysteine are depleted in crd1Δ cells. I have 
shown that crd1Δ exhibits decreased aconitase activity (Table 2.3), which is 
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expected to cause depletion of α-ketoglutarate, a precursor required for the 
synthesis of glutamate. Similarly, decreased activity of sulfite reductase (Table 
2.3) is expected to cause depletion of cysteine. These findings are supported by 
the observation that crd1Δ cells are auxotrophic for both glutamate and cysteine 
(Fig. 3.2). Because glutamate and cysteine are required for GSH synthesis, I 
hypothesize that GSH deficiency in crd1Δ is due to depletion of both amino 
acids. Amino acids analysis to quantify glutamate and cysteine levels in cell 
extracts from crd1Δ should be performed.  
II. How does GSH supplementation restore the growth of crd1Δ 
at elevated temperature? I suggest two possibilities. First, the synthesis of GSH 
may be decreased, as mentioned above. Alternatively, ROS produced in crd1Δ 
cells may exceed the cellular capacity to respond by synthesizing and 
regenerating GSH. This would be consistent with previous studies showing that 
crd1Δ exhibits elevated mitochondrial iron levels and increased ROS production 
(Chen et al., 2008a; Patil et al., 2012). Therefore, quantification of mitochondrial 
and cytosolic GSH should be carried out to determine if GSH levels or the 
GSH:GSSG ratio is decreased in crd1Δ. A decrease in GSH levels would 
suggest that GSH synthesis is perturbed, whereas a decrease in the GSH:GSSG 
ratio would be consistent with increased oxidative stress due to elevated ROS 
production. 
III.  Are activities of Fe-S enzymes restored by GSH 
supplementation? Previous reports have shown that Fe-S clusters in proteins 
such as aconitase and isopropylmalate isomerase are particularly sensitive to 
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degradation by ROS (Kispal et al., 1997; Kispal et al., 1999; Moreno-Cermeno et 
al., 2010; Vasquez-Vivar et al., 2000). Therefore, if ROS accounts for decreased 
activities of Fe-S enzymes, then GSH supplementation may restore the activities 
of aconitase and isopropylmalate isomerase to WT levels. 
4. Suppressors of crd1Δ growth deficiency at elevated temperature: 
In the suppressor screen described in chapter four, fifty putative 
suppressors of crd1Δ were obtained. From five sequenced suppressor plasmids, 
LEU2, which encodes the β-isopropylmalate dehydrogenase enzyme essential 
for the synthesis of leucine, was identified. An intriguing question is, how does 
overexpression of LEU2 alleviate the growth defect of crd1Δ when the control 
plasmid (YEp351), which contains the LEU2 marker, does not? The plasmid 
used in this study contains a 2-micron origin of replication, which maintains 50-
100 copies of the plasmid per cell (Zakian et al., 1979). The LEU2 insert in 
suppressors is expected to cause a two-fold increase in leucine content over the 
control plasmid. This would suggest that supplementation of excess leucine in 
the growth media may alleviate the growth defect of crd1Δ at elevated 
temperature. 
Interestingly, LEU2 was obtained as a suppressor that restored the growth 
of YFH1 point mutants (yfh1-) in respiratory conditions (Bedekovics et al., 2011). 
This study showed that leu2Δ abolished respiratory growth of yfh1, whereas 
overexpression of LEU2 restored growth of the mutant by activating expression 
of ACO1 (Bedekovics et al., 2011). The data presented in chapters two and three 
show that CL is required for mitochondrial Fe-S biogenesis and CL deficiency 
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leads to decreased Yfh1 protein, which suggests that in addition to the Fe-S 
defect, leu2Δ may exacerbate the phenotype of crd1Δ, causing the growth defect 
at elevated temperature. Therefore, overexpression of LEU2 may restore 
decreased activity of Aco1 by increasing ACO1 transcription. To determine if 
expression of ACO1 and the activity of the enzyme in crd1Δ are restored to WT 
levels, LEU2 should be overexpressed in a plasmid containing a different 
nutritional marker (e.g. URA3, TRP1, or HIS3). In addition to elucidating the role 
of LEU2 in crd1Δ, the 45 suppressor plasmids should be sequenced to identify 
the genes present. 
In summary, the findings presented in chapters two and three show for the 
first time that CL is required for maintaining Fe-S biogenesis and GSH 
homeostasis. However the mechanism linking CL to these two processes is not 
known. I invite my hard-working colleagues in the lab to identify the mechanism 
based on the questions proposed here.  
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Cardiolipin (CL) is the signature phospholipid of mitochondrial 
membranes, where it is synthesized locally and plays a critical role in 
mitochondrial bioenergetic functions. Inside the mitochondria, CL is a critical 
target of mitochondrial generated reactive oxygen species (ROS) and regulates 
signaling events related to apoptosis and aging. CL deficiency causes 
perturbation of signaling pathways outside the mitochondria, including the PKC-
Slt2 cell integrity pathway and the high osmolarity glycerol (HOG) pathway, and 
is a key player in the cross-talk between the mitochondria and the vacuole. The 
importance of CL in human health is underscored by the observation that 
perturbation of CL biosynthesis causes the severe genetic disorder Barth 
syndrome. 
In order to fully understand the cellular response to the loss of CL, 
genome-wide expression profiling was carried out in the yeast CL mutant crd1Δ. 
The results show that the loss of CL in this mutant leads to increased expression 
of iron uptake genes accompanied by elevated levels of mitochondrial iron and 
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increased sensitivity to iron and hydrogen peroxide. Previous studies have 
shown that increased mitochondrial iron levels result from perturbations in iron-
sulfur (Fe-S) cluster biogenesis. Consistent with an Fe-S defect, deletion of ISU1, 
one of two ISU genes that encode the mitochondrial Fe-S scaffolding protein 
essential for the synthesis of Fe-S clusters, led to synthetic growth defects with 
the crd1Δ mutant. The crd1Δ mutant exhibits decreased activities of 
mitochondrial Fe-S enzymes (aconitase, succinate dehydrogenase, and 
ubiquinol-cytochrome c oxidoreductase), as well as cytosolic Fe-S enzymes 
(sulfite reductase and isopropylmalate isomerase). Increased expression of 
ATM1 or YAP1, which encode proteins involved in the export of mitochondrial 
generated Fe-S co-factors to the cytosol and a transcription factor that regulates 
several antioxidant genes, respectively, did not rescue the Fe-S defects in crd1Δ. 
These findings show for the first time that CL is required for Fe-S biogenesis to 
maintain mitochondrial and cellular iron homeostasis. 
 Consistent with the role of CL in mitochondrial Fe-S biogenesis, 
perturbation of CL synthesis leads to decreased Yfh1 protein, a putative iron 
donor for mitochondrial Fe-S cluster assembly, and reduced activities of Fe-S 
enzymes aconitase and sulfite reductase, which are required for the synthesis of 
glutamate and sulfur-containing amino acids (methionine and cysteine). The data 
presented in this study show that the synthesis of glutamate and cysteine are 
decreased in crd1Δ. Interestingly, both amino acids are required for the synthesis 
of an essential antioxidant, glutathione (GSH), a tripeptide of glutamate, cysteine, 
and glycine. The growth defect of crd1Δ at elevated temperature and in the 
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presence of oxidants is rescued by GSH supplementation, which is consistent 
with decreased synthesis of GSH. Collectively, these findings indicate that GSH 
deficiency in crd1Δ is due to the depletion of precursors for GSH synthesis, 
which is caused by defective Fe-S biogenesis. 
 To obtain an understanding of CL functions that might explain the cellular 
defects in BTHS, a screen was carried out to identify genes that, when 
overexpressed, suppress the growth deficiency of crd1Δ in galactose-containing 
media at elevated temperature. The suppressor screen utilizing a high copy 
genomic DNA library led to the identification of fifty putative suppressors of 
crd1Δ. Five plasmids were intially sequenced, and interestingly, each plasmid 
contained the same region of chromosome III, spanning four genes. One of the 
genes was LEU2, which is involved in leucine biosynthesis, a process that is 
perturbed in the crd1Δ mutant. This supports the finding that perturbation of 
leucine synthesis likely contributes to the growth defect of crd1Δ.  
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